Malignant neoplasm of breast, ER-negative, including Hilmo

C3_BREAST_ERNEG_WIDE

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule only females	293218
2. Check conditions not RX_ERPLUS	276281
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — C50 Hospital discharge: ICD-9 — 174 Hospital discharge: ICD-8 — 174 Cause of death: ICD-10 — C50 Cause of death: ICD-9 — 174 Cause of death: ICD-8 — 174 Cancer registry: Topography ICD-O-3 — C50 Cancer registry: Morphology ICD-O-3 — ANY Cancer registry: Behaviour codes — [23] 3 out of 7 registries used, show all original rules.	9900
4. Check minimum number of events None	9900
5. Include endpoints None	9900
6. Filter based on genotype QC (FinnGen only)	9599

Control definitions (FinnGen only)

Control exclude: C3_CANCER, C3_CANCER_WIDE
Control conditions: not RX_ERPLUS

Extra metadata

First used in FinnGen datafreeze: DF12

NAME	C3_BREAST_ERNEG_WIDE
CONTROL_EXCLUDE	C3_CANCER\|C3_CANCER_WIDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS	!RX_ERPLUS
SEX	2
INCLUDE
PRE_CONDITIONS
CONDITIONS	!RX_ERPLUS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	C50
HD_ICD_9	174
HD_ICD_8	174
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	C50
COD_ICD_9	174
COD_ICD_8	174
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO	C50
CANC_TOPO_EXCL
CANC_MORPH	ANY
CANC_MORPH_EXCL
CANC_BEHAV	[23]

Similar endpoints

↥

List of similar endpoints to Malignant neoplasm of breast, ER-negative, including Hilmo based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Malignant neoplasm of breast, HER-negative

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	9599	9599	-
Unadjusted period prevalence (%)	3.40	3.40	-
Median age at first event (years)	58.56	58.56	-

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
9890: Matched controls
94189

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

C50.29

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland, other or undeterminated histology

+∞

312.6

304

WF049

NOMESCO Finland

Radiotherapy of metastasis

511.1

310.0

313

NK6AN

NOMESCO Finland

Total body bone isotope imaging

60.3

307.7

413

HA6AA

NOMESCO Finland

Extra corporeal mammography of operated mammary gland

99.8

307.7

2256

278

C44.31

ICD-10 Finland

Basocellular carcinoma of the skin on another or unspecified part of the face

42.2

307.7

445

105

YX9AD

NOMESCO Finland

Other CT eamination for dose design of radiotherapy

126.5

307.7

420

ZX090

NOMESCO Finland

Other technic of radiotherapy

484.9

307.7

665

C50.21

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor

+∞

307.7

1138

HAB99

NOMESCO Finland

Other partial excision of mammary gland

30.3

307.7

1133

400

D48.6

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Breast

8.0

307.7

554

693

A04AA01

ATC

ondansetron; systemic, rectal

7.9

307.7

1223

1647

WB401

NOMESCO Finland

Simple antibody therapy of primary tumour

+∞

307.7

428

PJA12

NOMESCO Finland

Sentinel node biopsy

3124.7

307.7

4934

TQB05

NOMESCO Finland

Puncture of skin of trunk

36.6

307.7

251

XX2AT

NOMESCO Finland

Other injection with ultrasound examination

26.5

307.7

463

174

HA1DG

NOMESCO Finland

Very extensive MRI examination of mammary gland with high intensity magnet

86.0

307.7

407

C50.40

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication

+∞

307.7

1067

8500/3-C50.4

ICD-O-3

Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast

+∞

307.7

1048

ZZR10

NOMESCO Finland

Flap of skin and muscle

93.4

307.7

295

H02AB02

ATC

dexamethasone; systemic

58.9

307.7

2634

577

WZC30

NOMESCO Finland

Teaching

3.3

307.7

1834

6102

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

9.9

307.7

824

859

PJD42

NOMESCO Finland

Excision of axillary lymph nodes

59.9

307.7

352

L02BA01

ATC

tamoxifen; oral

211.9

307.7

260

Z85.3

ICD-10 Finland

Personal history of malignant neoplasm of breast

1850.8

307.7

691

C50.41

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor

+∞

307.7

3737

8500/3-C50.2

ICD-O-3

Infiltrating duct carcinoma, NOS, of upper-inner quadrant of breast

+∞

307.7

368

L02BG04

ATC

letrozole; oral

27.1

307.7

606

226

HAE00

NOMESCO Finland

Reconstruction of breast using prosthesis

141.3

307.7

246

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

1668.2

307.7

929

ZZF00

NOMESCO Finland

Graft of adipose tissue

34.6

307.7

276

Z08.0

ICD-10 Finland

Follow-up examination after surgery for malignant neoplasm

37.7

307.7

285

130

Kela drug reimbursment

Malignant tumour

+∞

307.7

457

JN4AD

NOMESCO Finland

Body CT examination

4.7

307.7

939

2067

C50.49

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology

+∞

307.7

855

HA4AT

NOMESCO Finland

Labeling mammary gland pathology with ultrasound guidance

64.8

307.7

1405

240

HA4ST

NOMESCO Finland

Labeling mammary gland pathology with sterotactic guidance

81.0

307.7

281

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

190.8

307.7

422

JN4BD

NOMESCO Finland

Extensive body CT

6.5

307.7

1098

1778

9703

FHL

Breast resection

13.3

307.7

367

273

PJ3AT

NOMESCO Finland

Cytology of lymphnode with ultrasound guidance

34.9

307.7

250

YG1AD

NOMESCO Finland

CT examination of thorax for dose design of radiotherapy

934.8

307.7

893

PJ5AN

NOMESCO Finland

Localisation of sentinell lymphnode with isotope imaging

2096.2

307.7

1108

8090/3-C44.9

ICD-O-3

Basal cell carcinoma, NOS, of skin, NOS

+∞

307.7

406

HAE20

NOMESCO Finland

Reconstruction of areola and mamilla using graft or flap

485.6

307.7

710

N63

ICD-10 Finland

Unspecified lump in breast

6.1

307.7

1761

3248

HAB00

NOMESCO Finland

Excision of lesion of mammary gland

6.6

307.7

718

1099

HA1BG

NOMESCO Finland

MRI examination of mammary gland with high intensity magnet

56.6

307.7

322

XX1XN

NOMESCO Finland

Other isotope examination

836.2

307.7

421

QB2S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in chest

52.0

307.7

219

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

598.9

307.7

1801

HAD30

NOMESCO Finland

Reduction mammoplasty with transposition of areola

6.0

307.7

917

1572

PJD52

NOMESCO Finland

Block dissection of axillary lymph nodes

4705.2

307.7

1693

A04AA02

ATC

granisetron; systemic, transdermal

376.6

307.7

1275

HAE99

NOMESCO Finland

Other reconstruction of breast

76.2

307.7

392

C50.91

ICD-10 Finland

Malignant tumor in another specified localization in ductal mammary gland

7858.4

307.7

772

HWD00

NOMESCO Finland

Reoperation for deep haemorrhage in surgery of mammary gland

30.0

307.7

231

Z80.3

ICD-10 Finland

Family history of malignant neoplasm of breast

17.8

307.7

589

333

115

Kela drug reimbursment

Breast cancer

+∞

307.7

3027

HA003

NOMESCO Finland

Radiotherapy after partial ablation of mammary gland

1701.1

307.7

2903

HA013

NOMESCO Finland

Radiotherapy after total ablation of mammary gland

+∞

307.7

507

ZX080

NOMESCO Finland

Image guided radiotherapy

1817.6

307.7

570

Z42.1

ICD-10 Finland

Follow-up care involving plastic surgery of breast

25.7

307.7

242

C50.11

ICD-10 Finland

Malignant tumor of the central part of the mammary gland,ductal tumor

6297.9

307.7

630

C50.31

ICD-10 Finland

Malignant tumor of the lower inner quadrant of the mammary gland, ductal tumor

+∞

307.7

502

C50.81

ICD-10 Finland

Overall malignant tumor of the mammary gland, ductal tumor

+∞

307.7

690

D05.1

ICD-10 Finland

Intraductal carcinoma in situ

597.9

307.7

2160

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

14884.8

307.7

1361

C50.99

ICD-10 Finland

Breast, unspecified

3953.3

307.7

1773

WX404

NOMESCO Finland

Intravenous generell anesthesy

3.6

307.7

3065

10339

C50.51

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor

+∞

307.7

735

D70.82

ICD-10 Finland

Drug-induced neutropenia

25.5

307.7

246

8500/2-C50.9

ICD-O-3

Intraductal carcinoma, noninfiltrating, NOS, of breast, NOS

+∞

307.7

1403

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

318.4

307.7

447

HAB50

NOMESCO Finland

Partial excision of mammary gland with reconstructive operation

527.6

307.7

1129

A04AA55

ATC

palonosetron, combinations; systemic

5920.4

307.7

1126

1744A

ICD-9 Finland

Malignant neoplasm of female breast, Upper-outer quadrant

+∞

307.7

501

L03AA13

ATC

pegfilgrastim; parenteral

2528.5

307.7

1223

YG1BD

NOMESCO Finland

Extensive CT examination of thorax for dose design of radiotherapy

3288.0

307.7

1525

X76

ICPC

Malignant neoplasm breast female

1322.3

307.7

769

5702

FHL

Local lymph node removal (eg armpit, groin)

80.7

307.7

183

A04AD12

ATC

aprepitant; systemic

635.7

307.7

508

HAB40

NOMESCO Finland

Wedge excision of mammary gland

199.4

307.7

3473

255

HA1AT

NOMESCO Finland

Biopsy of mammary glands with ultrasound guidance

34.7

307.7

895

269

WB121

NOMESCO Finland

Demanding neoadjuvant cytostatic therapy

+∞

307.7

364

HA3AT

NOMESCO Finland

Pucture of mammary gland cyst with ultrasound examination

39.8

307.7

229

8520/3-C50.9

ICD-O-3

Lobular carcinoma, NOS, of breast, NOS

+∞

307.7

420

WZC00

NOMESCO Finland

Treatment plan or consultation

3.2

307.7

4428

19154

WX402

NOMESCO Finland

General anaesthesia

3.1

307.7

2588

9691

WF002

NOMESCO Finland

Radical radiotherapy

51.0

307.7

455

HA1AA

NOMESCO Finland

X-ray mammography

23.6

307.7

3330

1987

9707

FHL

Ablation of mammae and removal of axillary lymph nodes

797.5

307.7

479

THW99

NOMESCO Finland

Other minor procedure in surgery of mammary gland

124.8

307.7

851

C50.90

ICD-10 Finland

Malignant tumor in other or unspecified location in mammary gland without histology

8872.9

307.7

862

XX3DW

NOMESCO Finland

Time consuming IT work

12.2

307.7

2102

2043

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

24.6

307.7

2747

1451

HAE10

NOMESCO Finland

Reconstruction of breast using graft or flap

396.4

307.7

873

L03AA14

ATC

lipegfilgrastim; parenteral

3633.0

307.7

377

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

91.8

307.7

226

A03FA01

ATC

metoclopramide; systemic, rectal

5.8

307.7

3706

8868

D05.9

ICD-10 Finland

Carcinoma in situ of breast, unspecified

201.9

307.7

248

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

122.7

307.7

202

L01BC06

ATC

capecitabine; oral

+∞

307.7

799

C50.42

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor

+∞

307.7

498

8500/3-C50.9

ICD-O-3

Infiltrating duct carcinoma, NOS, of breast, NOS

+∞

307.7

3539

HAC15

NOMESCO Finland

Subcutaneous mastectomy with excision of mamilla

390.7

307.7

469

TQW20

NOMESCO Finland

Tatoe

203.0

307.7

582

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

+∞

307.7

360

C50

ICD-10 Finland

Malignant neoplasm of breast

2192.7

307.7

1316

C50.9

ICD-10 Finland

Malignant neoplasm: Breast, unspecified

857.5

307.7

348

HA6BA

NOMESCO Finland

Breast tomosynthesis specimen

66.5

307.7

402

HA1CG

NOMESCO Finland

Extensive MRI examination of mammary gland with high intensity magnet

57.0

307.7

634

113

WF003

NOMESCO Finland

Adjuvant radiotherapy

492.0

307.7

763

HAC20

NOMESCO Finland

Total mastectomy

1158.2

307.7

2254

HAD99

NOMESCO Finland

Other plastic operation on breast

31.1

307.7

242

Z31.5

ICD-10 Finland

Genetic counselling

7.6

307.7

1101

1525

C50.4

ICD-10 Finland

Malignant neoplasm: Upper-outer quadrant of breast

+∞

307.7

540

HA1TE

NOMESCO Finland

Supplementary or limited ultrasound examination of mammary glands

17.8

307.7

350

194

L03AA02

ATC

filgrastim; parenteral

118.3

307.7

428

Z51.5

ICD-10 Finland

Palliative care

5.2

290.2

638

1240

PJ2AT

NOMESCO Finland

Biopsy of lymphnode with ultrasound guidance

47.9

285.4

173

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

5.9

280.1

534

910

C50.00

ICD-10 Finland

Malignant tumor of nipple and areola, no histological veryfication

+∞

278.5

271

17402

ICD-8 Finland

Malignant neoplasm of breast, Glandulae

+∞

272.3

265

HAD40

NOMESCO Finland

Mastopexy

28.8

269.8

187

ZXE10

NOMESCO Finland

More than one and less than three hours

2.1

267.4

4018

22993

C44.51

ICD-10 Finland

Basocellular carcinoma of the skin on the torso

28.9

267.4

185

R4110

NOMESCO Finland

Physiotherapy

2.2

260.6

3130

16384

HAD60

NOMESCO Finland

Replacement of prosthetic implant in breast

85.7

257.7

142

ZX112

NOMESCO Finland

Subcutaneous

11.2

255.7

279

244

XZZ00

NOMESCO Finland

Active surveillance of a diagnosed cancer

819.6

252.5

252

HA4MT

NOMESCO Finland

Labeling mammary gland pathology with X-ray guidance

65.3

248.0

142

HA1HA

NOMESCO Finland

Tomosynthesis mammography

30.3

247.9

169

A79

ICPC

Malignancy NOS

74.0

245.6

138

1CD02, ,

NOMESCO Finland

+∞

235.1

229

HAE05

NOMESCO Finland

Reconstruction of breast using soft tissue and prosthesis

331.9

233.8

240

HA3ST

NOMESCO Finland

Removal of lesion of breast with radiological guidance

25.3

230.5

167

8500/3-C50.5

ICD-O-3

Infiltrating duct carcinoma, NOS, of lower-outer quadrant of breast

+∞

228.9

223

NK6BQ

NOMESCO Finland

Whole body extensive bone SPET with low dose CT

92.7

228.9

125

HWA00

NOMESCO Finland

Repair of wound dehiscence in surgery of mammary gland

43.3

224.3

139

C50.89

ICD-10 Finland

Overall malignant tumor of the mammary gland, other or undeterminated histology

+∞

223.8

218

HAC10

NOMESCO Finland

Subcutaneous mastectomy with preservation of mamilla

113.7

220.8

118

C50.19

ICD-10 Finland

Malignant tumor of the central part of the mammary gland, other or undeterminated histology

+∞

217.6

212

C50.20

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,no histological veryfication

+∞

214.5

209

HAC25

NOMESCO Finland

Radical mastectomy

+∞

213.5

208

X21

ICPC

Breast sympt/compl female other

5.4

211.9

434

789

HA2AT

NOMESCO Finland

Cytology of mammary gland with ultrasound guidance

32.2

209.2

140

WX702

NOMESCO Finland

Supraglottic ventilation device

3.5

208.2

763

2175

HAD50

NOMESCO Finland

Removal of prosthetic implant from breast

20.8

203.5

159

HA1SA

NOMESCO Finland

Expansion mammography

45.2

198.8

122

WZC15, ,

NOMESCO Finland

46.3

196.5

120

ZX120

NOMESCO Finland

Intravenous

3.0

196.1

932

3112

ZSH00

NOMESCO Finland

Procedure related to previous procedure classified in chapter H

277.8

192.0

199

HWH99

NOMESCO Finland

Other reoperation in surgery of mammary gland

45.1

190.5

117

WB123

NOMESCO Finland

Demanding adjuvant cytostatic therapy

1714.7

188.6

186

Z08.7

ICD-10 Finland

Follow-up examination after combined treatment for malignant neoplasm

98.1

187.9

102

8090/3-C44.3

ICD-O-3

Basal cell carcinoma, NOS, of skin of other and unspecified parts of face

+∞

186.7

182

FM1FN

NOMESCO Finland

Heart function isotope examination

1805.6

179.3

177

WX408

NOMESCO Finland

General anesthesy, balanced

2.0

178.8

2494

13490

Z51.0

ICD-10 Finland

Radiotherapy session

257.2

177.8

185

WB402

NOMESCO Finland

Demanding antibody therapy of primary tumour

+∞

174.3

170

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

293.2

174.2

180

WB203

NOMESCO Finland

Simple adjuvant hormone therapy of malignancy

+∞

173.3

169

C50.10

ICD-10 Finland

Malignant tumor of the central part of the mammary gland, no histological veryfication

+∞

173.3

169

I97.2

ICD-10 Finland

Postmastectomy lymphoedema syndrome

286.3

170.1

176

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

1697.5

170.1

168

ZZQ10

NOMESCO Finland

Free microvascular graft of skin and muscle

817.5

169.2

169

8500/3-C50.3

ICD-O-3

Infiltrating duct carcinoma, NOS, of lower-inner quadrant of breast

+∞

168.2

164

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

44.6

165.6

102

C54.11

ICD-10 Finland

Adenocarcinoma of the endometrium

+∞

164.1

160

HA1S1

NOMESCO Finland

Photography of breasts

68.8

163.6

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

3.5

161.9

591

1675

QBE20

NOMESCO Finland

Excision and repair of scar or web of skin of trunk

10.8

161.5

179

160

C50.2

ICD-10 Finland

Malignant neoplasm: Upper-inner quadrant of breast

+∞

157.9

154

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

3.1

157.2

690

2192

9706

FHL

Ablation mammae, includes axillary exploration

+∞

155.8

152

C50.59

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, other or undeterminated histology

+∞

155.8

152

ZZQ00

NOMESCO Finland

Free microvascular graft of skin

176.4

154.1

164

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

3.5

151.5

542

1515

8010/3-C50.9

ICD-O-3

Carcinoma, NOS, of breast, NOS

+∞

150.7

147

1749X

ICD-9 Finland

Malignant neoplasm of female breast, Breast (female), unspecified

+∞

146.6

143

ZXA05

NOMESCO Finland

Left side

1.8

146.1

2742

16196

N64.9

ICD-10 Finland

Disorder of breast, unspecified

6.2

145.6

255

398

128

Kela drug reimbursment

Cancers of female genital organs

357.8

145.6

149

C50.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of breast

+∞

145.5

142

C79.5

ICD-10 Finland

Secondary malignant neoplasm of bone and bone marrow

+∞

144.5

141

XX2RW, ,

NOMESCO Finland

11.3

143.6

155

133

WD325

NOMESCO Finland

Demanding therapy of methastized malignancy with biomodifiers

39.3

141.9

C50.39

ICD-10 Finland

Malignant tumor of the lower inner quadrant of the mammary gland, other or undeterminated histology

+∞

140.4

137

HA1CM

NOMESCO Finland

Mammary gland extensive MRI examination with 3 Tesla magnet

29.8

140.1

ZXA00

NOMESCO Finland

Right side

1.8

139.7

2900

17622

C50.22

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,lobular tumor

+∞

139.4

136

OAA41

NOMESCO Finland

Health check based on individual needs

63.2

137.0

ZX070

NOMESCO Finland

Intensity modified radiotherapy

175.2

136.2

145

B01AB05

ATC

enoxaparin; parenteral

1.8

135.4

3178

19979

8500/3-C50.1

ICD-O-3

Infiltrating duct carcinoma, NOS, of central portion of breast

+∞

135.3

132

WF004

NOMESCO Finland

Palliative radiotherapy

330.6

134.4

138

ZXD10

NOMESCO Finland

Scheduled procedure

1.7

134.1

3917

26148

Z51.1

ICD-10 Finland

Chemotherapy session for neoplasm

328.2

133.4

137

1742A

ICD-9 Finland

Malignant neoplasm of female breast, Upper-inner quadrant

+∞

132.2

129

D05.0

ICD-10 Finland

Lobular carcinoma in situ

222.1

131.6

138

C44.41

ICD-10 Finland

Basocellular carcinoma of the skin of the scalp and neck

33.4

131.4

WB133

NOMESCO Finland

Very demanding adjuvant cytostatic therapy

+∞

130.1

127

HAA10

NOMESCO Finland

Biopsy of mammary gland

7.4

130.0

194

255

C50.82

ICD-10 Finland

Overall malignant tumor of the mammary gland, lobular tumor

1214.6

127.0

126

ZZR00

NOMESCO Finland

Flap of skin

10.9

127.0

140

124

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

6.5

125.8

211

315

D24

ICD-10 Finland

Benign neoplasm of breast

4.0

125.4

372

912

QXB05

NOMESCO Finland

Skin wound assessment, unspecified location

16.9

124.9

107

JN4CD

NOMESCO Finland

Very extensive body CT

5.3

122.3

255

470

XX3AT

NOMESCO Finland

Other labeling with ultrasound guidance

30.7

122.2

C78.0

ICD-10 Finland

Secondary malignant neoplasm of lung

1165.7

121.9

121

ZX013

NOMESCO Finland

Radiotherapy with large shaped fields - SSD therapy

+∞

121.9

119

C50.80

ICD-10 Finland

Overall malignant tumor of the mammary gland, no histological veryfication

+∞

121.9

119

C77.3

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Axillary and upper limb lymph nodes

+∞

120.9

118

WW500

NOMESCO Finland

Blood transfusion

4.4

119.0

307

677

YX9BD

NOMESCO Finland

Other extensive CT eamination for dose design of radiotherapy

200.9

118.5

125

N02AA05

ATC

oxycodone; systemic

2.0

117.5

1539

8009

9725

FHL

Reconstruction of the mammary gland with foreign material (after removal)

36.5

117.5

8500/3-C50.8

ICD-O-3

Infiltrating duct carcinoma, NOS, of overlapping lesion of breast

+∞

116.8

114

C50.1

ICD-10 Finland

Malignant neoplasm: Central portion of breast

1107.2

115.8

115

C50.93

ICD-10 Finland

Malignant tumor in other specified localization in mammary gland other or unspecified histology

+∞

115.8

113

L01CA04

ATC

vinorelbine; systemic

+∞

114.7

112

YG1CD

NOMESCO Finland

Very extensive CT examination of thorax for dose design of radiotherapy

+∞

114.7

112

HA6HA

NOMESCO Finland

Tomosynthesis assessment of mammary gland specimen

132.9

114.0

124

C50.92

ICD-10 Finland

Malignant tumor in another specified localization in lobular gland, lobular tumor

1087.7

113.7

113

X19

ICPC

Breast lump/mass female

4.6

112.8

277

587

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.6

111.0

4214

29652

HAD20

NOMESCO Finland

Liposuction of breast

28.4

110.7

C20.91

ICD-10 Finland

Malignant tumor of the rectum invasive carcinoma

+∞

110.6

108

8520/3-C50.4

ICD-O-3

Lobular carcinoma, NOS, of upper-outer quadrant of breast

+∞

110.6

108

C79.30

ICD-10 Finland

Secondary malignant tumor of the cerebrum

+∞

109.6

107

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

4.6

107.7

262

551

C50.5

ICD-10 Finland

Malignant neoplasm: Lower-outer quadrant of breast

+∞

107.5

105

QBE30

NOMESCO Finland

Excision and repair of surgical scar in trunk

9.5

107.2

130

132

1XC03, ,

NOMESCO Finland

518.2

106.9

108

TPX10

NOMESCO Finland

Implantation of vascular injection port

4.8

106.2

245

493

ZXE30

NOMESCO Finland

More than five and less than seven hours

3.3

104.1

416

1244

PJA10

NOMESCO Finland

Exploration of lymph nodes

9.9

101.9

120

117

C50.01

ICD-10 Finland

Malignant tumor of nipple and areola, ductal tumor

+∞

101.4

B01AB10

ATC

tinzaparin; parenteral

2.2

100.1

895

4017

9719

FHL

Other measure in this category

18.5

98.7

C50.50

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, no histological veryfication

+∞

97.3

8090/3-C44.5

ICD-O-3

Basal cell carcinoma, NOS, of skin of trunk

+∞

97.3

OAB38

NOMESCO Finland

Psychosocial guidance and counselling

50.5

96.5

8500/2-C50.4

ICD-O-3

Intraductal carcinoma, noninfiltrating, NOS, of upper-outer quadrant of breast

+∞

96.3

N64.5

ICD-10 Finland

Other signs and symptoms in breast

3.2

95.9

399

1223

HAD00

NOMESCO Finland

Augmentation mammoplasty

53.6

94.2

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.2

93.6

898

4143

X26

ICPC

Fear of breast cancer female

7.4

93.4

139

182

8380/3-C54.1

ICD-O-3

Endometrioid adenocarcinoma, NOS, of endometrium

+∞

93.2

HA1DA

NOMESCO Finland

Restricted mammography

31.3

91.7

C50.12

ICD-10 Finland

Malignant tumor of the central part of the mammary gland,lobular tumor

+∞

91.1

C50.30

ICD-10 Finland

Malignant tumor of the lower inner quadrant of the mammary gland, no histological veryfication

+∞

91.1

ZXE00

NOMESCO Finland

One hour or less

1.6

90.7

3678

25915

1748X

ICD-9 Finland

Malignant neoplasm of female breast, Other specified sites of female breast

+∞

89.1

HA1ST

NOMESCO Finland

Biopsy of mammary gland with sterotactic guidance

30.3

87.9

YA1BD

NOMESCO Finland

Extensive CT examination of head and neck for dose design of radiotherapy

43.1

86.8

TQW99

NOMESCO Finland

Other minor procedure on skin

2.8

86.7

443

1526

N60.8

ICD-10 Finland

Other benign mammary dysplasias

8.6

86.2

113

127

JN6AD

NOMESCO Finland

CT of torso and neck

8.6

85.4

112

126

XX1AD

NOMESCO Finland

Other CT-examination

113.0

85.3

8510/3-C50.9

ICD-O-3

Medullary carcinoma, NOS, of breast, NOS

+∞

85.0

1745A

ICD-9 Finland

Malignant neoplasm of female breast, Lower-outer quadrant

+∞

84.0

8520/2-C50.9

ICD-O-3

Lobular carcinoma in situ, NOS, of breast, NOS

+∞

84.0

C50.52

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, lobular tumor

+∞

81.9

R50.9

ICD-10 Finland

Fever, unspecified

1.9

80.4

1159

6173

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

4.6

79.5

195

413

QBJ00

NOMESCO Finland

Liposuction in trunk

8.4

79.4

106

122

Z08.9

ICD-10 Finland

Follow-up examination after unspecified treatment for malignant neoplasm

22.6

78.2

C64.88

ICD-10 Finland

Other malignant neoplasm of kidney, except renal pelvis

747.5

78.0

9702

FHL

Breast exploration and possible tumor removal

3.5

77.8

280

783

C44.32

ICD-10 Finland

Spinocellular carcinoma of the skin on another or unspecified part of the face

23.1

77.5

PJW99

NOMESCO Finland

Other operation on lymphatic system

377.0

77.4

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.9

77.0

1002

5154

WB610

NOMESCO Finland

Demanding neoadjuvant therapy of tumour with antibodies

+∞

76.8

WX302

NOMESCO Finland

Thoracal epidural anesthesy

3.2

76.4

309

930

C44.61

ICD-10 Finland

Basocellular carcinoma of the skin of the upper extremity including the shoulder

24.4

76.3

AA1BD

NOMESCO Finland

Extensive CT of head and brain

3.8

76.1

240

614

8140/3-C20.9

ICD-O-3

Adenocarcinoma, NOS, of rectum, NOS

728.1

76.0

ZXE20

NOMESCO Finland

More than three and less than five hours

1.9

75.8

1074

5683

Z3231

NOMESCO Finland

Registered nurse

1.6

75.4

2402

15875

C73.91

ICD-10 Finland

Papillary carcinoma of the thyroid gland (thyroid gland)

367.3

75.4

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

5.0

75.1

164

315

XX9TE

NOMESCO Finland

Compementary ultrasound examination

7.6

74.6

108

137

TPH07

NOMESCO Finland

Cathetrisation of artery

2.0

74.2

830

4047

C50.3

ICD-10 Finland

Malignant neoplasm: Lower-inner quadrant of breast

+∞

73.7

A04AA03

ATC

tropisetron; systemic

35.3

73.4

WD135

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

243.4

73.0

8260/3-C73.9

ICD-O-3

Papillary adenocarcinoma, NOS, of thyroid gland

+∞

72.7

XX1XT

NOMESCO Finland

Other puncture with other radiological guidance

21.4

72.7

C20.90

ICD-10 Finland

Malignant tumor of the rectum without histology

352.7

72.4

GDC01

NOMESCO Finland

Thoracoscopic lobectomy of lung

43.0

72.2

C44.71

ICD-10 Finland

Basocellular carcinoma of the skin of the lower extremity including the hip

25.7

70.8

8503/2-C50.9

ICD-O-3

Noninfiltrating intraductal papillary adenocarcinoma of breast, NOS

+∞

69.6

C56.71

ICD-10 Finland

Serous epithelial malignant tumor of the ovary

+∞

69.6

8480/3-C50.9

ICD-O-3

Mucinous adenocarcinoma of breast, NOS

+∞

69.6

N05CB02

ATC

barbiturates in combination with other drugs

2.6

68.6

424

1608

D05.7

ICD-10 Finland

Other carcinoma in situ of breast

650.7

67.8

QBA00

NOMESCO Finland

Puncture of skin of trunk

10.6

67.8

HA1AE, ,

SPAT

2.8

67.1

349

1212

R92

ICD-10 Finland

Abnormal findings on diagnostic imaging of breast

6.7

66.5

107

153

HA1RA

NOMESCO Finland

Combined assessment of mammary gland (mammography and ultrasound)

3.1

65.9

293

933

9724

FHL

Breast augmentation or reconstruction with own tissue

26.5

65.8

8140/3-C50.9

ICD-O-3

Adenocarcinoma, NOS, of breast, NOS

+∞

65.5

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.4

64.7

3830

28592

L02BG06

ATC

exemestane; oral

+∞

64.5

EP1AE

NOMESCO Finland

Neck ultrasound examination

2.3

64.3

497

2089

C83.31

ICD-10 Finland

Diffuse lymphoma with large B cells

214.1

64.0

Z40.0

ICD-10 Finland

Prophylactic surgery for risk-factors related to malignant neoplasms

16.7

62.7

17409

ICD-8 Finland

Malignant neoplasm of breast, Unspecified

+∞

62.4

ZXE40

NOMESCO Finland

More than seven and less than nine hours

3.8

62.3

194

492

PJD64

NOMESCO Finland

Laparoscopic dissection of iliac lymph nodes

201.3

59.9

S77

ICPC

Malignant neoplasm of skin

15.2

59.8

C78.6

ICD-10 Finland

Secondary malignant neoplasm of retroperitoneum and peritoneum

+∞

59.4

A02BC02

ATC

pantoprazole; systemic

1.4

58.9

6677

55638

Z3226

NOMESCO Finland

Physiotherapist

1.6

58.5

1652

10532

1743A

ICD-9 Finland

Malignant neoplasm of female breast, Lower-inner quadrant

+∞

58.3

1741A

ICD-9 Finland

Malignant neoplasm of female breast, Central portion

+∞

58.3

N61

ICD-10 Finland

Inflammatory disorders of breast

3.0

57.9

263

848

HA1BA

NOMESCO Finland

Extensive X-ray mammography

7.1

57.5

119

C50.09

ICD-10 Finland

Malignant tumor of nipple and areola, other or undeterminated histology

+∞

57.3

N02BE01

ATC

paracetamol; systemic, rectal

1.7

57.2

8819

78048

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

7.8

57.0

PJ1AN

NOMESCO Finland

Lymphsystem isotope imaging

23.6

56.5

Z80.4

ICD-10 Finland

Family history of malignant neoplasm of genital organs

8.4

56.4

C50.32

ICD-10 Finland

Malignant tumor of the lower inner quadrant of the mammary gland, lobular tumor

+∞

56.3

166

Kela drug reimbursment

Dalteparin and tinzaparin (treatment for more than 6 months)

279.6

56.2

XX1AT

NOMESCO Finland

Other puncture with ultrasound guidance

4.8

56.1

130

263

PD1BD

NOMESCO Finland

Extensive CT of abdominal aorta and branches

7.4

55.3

107

2393A

ICD-9 Finland

Neoplasm of unspecified nature, Breast

5.8

54.6

102

170

XX2VW

NOMESCO Finland

Radiologic consultation

6.4

54.3

139

TPH04

NOMESCO Finland

Cathetrisation of vein

1.5

53.6

1754

11540

YL1BD

NOMESCO Finland

Extensive CT examination of pelvis for dose design of radiotherapy

+∞

53.2

ZSZ00

NOMESCO Finland

Primary repair operation

505.8

52.5

C34.32

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma

+∞

52.2

WB321

NOMESCO Finland

Multiple adjuvant therapy of malignancy with biomodifiers

+∞

52.2

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.9

51.8

713

3719

C56

ICD-10 Finland

Malignant neoplasm of ovary

109.2

51.7

S18

ICPC

Laceration/cut

1.4

51.7

3973

30684

C18.71

ICD-10 Finland

Malignant tumor of the sigmoid invasive carcinoma

+∞

51.2

N62

ICD-10 Finland

Hypertrophy of breast

2.2

50.8

476

2164

D05

ICD-10 Finland

Carcinoma in situ of breast

+∞

50.1

8380/3-C54.9

ICD-O-3

Endometrioid adenocarcinoma, NOS, of corpus uteri

+∞

50.1

C34.12

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma

+∞

50.1

Y83.4

ICD-10 Finland

Other reconstructive surgery as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

14.7

50.0

WD505

NOMESCO Finland

Simple enzyme inhibitor or similar therapy of methastized malignancy

476.8

49.5

GD1CT

NOMESCO Finland

Biopsy of the lung with CT guidance

7.5

49.5

Z31.6

ICD-10 Finland

General counselling and advice on procreation

8.4

48.3

XX9AW

NOMESCO Finland

Production of copy from X-ray picture

2.4

48.2

338

1360

C56.00

ICD-10 Finland

Malignant tumor of the ovary without histology

239.5

48.1

YA1AD

NOMESCO Finland

CT examination of head and neck for dose design of radiotherapy

11.7

47.6

N06AX16

ATC

venlafaxine; oral

1.6

47.5

1316

8316

3AA13, ,

NOMESCO Finland

457.5

47.5

8000/3-C50.9

ICD-O-3

Neoplasm, malignant of breast, NOS

+∞

47.1

C44.11

ICD-10 Finland

Basocellular carcinoma of the skin of the eyelids including the corner of the eye

65.7

47.0

J70.0

ICD-10 Finland

Acute pulmonary manifestations due to radiation

229.7

46.1

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

2.5

45.1

282

1075

C25.0

ICD-10 Finland

Malignant neoplasm: Head of pancreas

+∞

45.0

C67.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bladder

+∞

45.0

C44.30

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face without histology

81.4

44.9

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

2.3

44.9

336

1392

LAF11

NOMESCO Finland

Laparoscopic bilateral salpingo-oophorectomy

1.9

44.4

590

3038

C18.21

ICD-10 Finland

Malignant tumor of the ascending colon invasive carcinoma

+∞

44.0

WB101

NOMESCO Finland

Simple cytostatic neoadjuvant therapy

+∞

44.0

PJD41

NOMESCO Finland

Excision of cervical lymph nodes

6.2

43.3

116

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

1.8

43.1

742

4138

8211/3-C50.9

ICD-O-3

Tubular adenocarcinoma of breast, NOS

+∞

43.0

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

4.2

42.7

116

267

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

2.0

42.4

472

2287

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

1.9

42.2

551

2821

YX9AW, ,

NOMESCO Finland

210.4

42.1

N60.9

ICD-10 Finland

Benign mammary dysplasia, unspecified

4.8

42.1

192

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.9

42.0

539

2744

WD225

NOMESCO Finland

Demanding therapy of methastized malignancy with hormones

+∞

41.9

WB111

NOMESCO Finland

Multiple neoadjuvant cytostatic therapy

+∞

41.9

WX110

NOMESCO Finland

Infiltration anesthesia

1.3

41.2

6260

52923

WX704

NOMESCO Finland

Intubation

1.8

41.1

646

3506

J01MA12

ATC

levofloxacin; systemic

1.5

41.0

1409

9319

8070/3-C44.9

ICD-O-3

Squamous cell carcinoma, NOS, of skin, NOS

+∞

40.9

C82.1

ICD-10 Finland

Follicular lymphoma grade II

+∞

40.9

C79.31

ICD-10 Finland

Secondary malignant tumor of the cerebellum

+∞

40.9

QBA25

NOMESCO Finland

Destruction of lesion of skin of trunk

4.3

40.5

105

233

JAL30

NOMESCO Finland

Omentectomy

5.2

40.4

155

2330A

ICD-9 Finland

Carcinoma in situ of breast and genito-urinary system, Breast

390.0

40.4

L57.0

ICD-10 Finland

Actinic keratosis

1.7

40.1

822

4811

8140/3-C18.7

ICD-O-3

Adenocarcinoma, NOS, of sigmoid colon

+∞

39.9

C50.0

ICD-10 Finland

Malignant neoplasm: Nipple and areola

+∞

39.9

GD1AD

NOMESCO Finland

Thorax CT examination

2.1

39.1

370

1688

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.7

38.9

697

3930

JN6BD

NOMESCO Finland

Extensive CT of torso and neck

9.2

38.8

C90.0

ICD-10 Finland

Multiple myeloma

130.7

37.9

156

Kela drug reimbursment

Lapatinib

+∞

37.8

8090/3-C44.1

ICD-O-3

Basal cell carcinoma, NOS, of eyelid

+∞

37.8

N64.8

ICD-10 Finland

Other specified disorders of breast

4.4

37.5

203

R18

ICD-10 Finland

Ascites

3.7

37.3

120

312

C18.00

ICD-10 Finland

Malignant tumor of the caecum without histology

361.0

37.3

C34.1

ICD-10 Finland

Malignant neoplasm: Upper lobe, bronchus or lung

+∞

36.8

9721

FHL

Mamilla reconstruction or transposition

47.8

36.7

QBB05

NOMESCO Finland

Revision of wound of skin of trunk

4.1

36.4

100

232

C20

ICD-10 Finland

Malignant neoplasm of rectum

351.4

36.3

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

2.8

36.3

182

621

1740A

ICD-9 Finland

Malignant neoplasm of female breast, Nipple and areola

+∞

35.8

DHB00

NOMESCO Finland

Excision of lesion of external nose

7.8

35.8

HAD10

NOMESCO Finland

Augmentation of breast using prosthesis

6.4

35.3

L02BG03

ATC

anastrozole; oral

65.2

35.2

WF099

NOMESCO Finland

Other radiotherapy

9.0

34.9

C18.01

ICD-10 Finland

Malignant tumor of the caecum invasive carcinoma

+∞

34.8

8310/3-C64.9

ICD-O-3

Clear cell adenocarcinoma, NOS, of kidney, NOS

+∞

34.8

T85.4

ICD-10 Finland

Mechanical complication of breast prosthesis and implant

7.0

34.6

D04.5

ICD-10 Finland

Carcinoma in situ: Skin of trunk

5.9

34.4

100

QBE99

NOMESCO Finland

Other excision or repair of lesion of skin of trunk

3.0

34.3

151

479

PJD54

NOMESCO Finland

Block dissection of iliac lymph nodes

63.7

34.2

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.4

34.2

233

926

C18.70

ICD-10 Finland

Malignant tumor of the sigmoid without histology

172.0

34.1

WPA10

NOMESCO Finland

Proactive palliative care treatment plan

11.0

34.0

WB303

NOMESCO Finland

Simple adjuvant therapy of malignancy with biomodifiers

+∞

33.8

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.4

33.6

245

1004

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.4

33.6

227

899

JFB30

NOMESCO Finland

Right hemicolectomy

5.2

33.4

130

SPAT1269

SPAT

Other puncture and/or drainage

5.8

33.4

103

J01DB01

ATC

cefalexin; oral

1.4

33.0

7598

66920

HAB20

NOMESCO Finland

Excision of lactiferous duct

5.8

32.9

101

8461/3-C56.9

ICD-O-3

High grade serous carcinoma of ovary

+∞

32.7

WD205

NOMESCO Finland

Therapy of methastized malignancy with hormones

+∞

32.7

PJ5AQ

NOMESCO Finland

Sentinell lymphnode SPECT with low dose CT

+∞

32.7

C91.1

ICD-10 Finland

Chronic lymphocytic leukaemia of B-cell type

47.8

32.7

R59.0

ICD-10 Finland

Localized enlarged lymph nodes

2.5

32.7

208

801

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

3.0

32.6

146

468

C77.0

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck

312.8

32.3

C25.9

ICD-10 Finland

Malignant neoplasm: Pancreas, unspecified

162.4

32.1

B29

ICPC

Lymph/immune mech sympt/complt other

6.1

31.9

8090/3-C44.4

ICD-O-3

Basal cell carcinoma, NOS, of skin of scalp and neck

+∞

31.7

WC125

NOMESCO Finland

Demanding cytostatic therapy of local tumor recidive

+∞

31.7

L01XE07

ATC

[U] lapatinib

+∞

31.7

8520/3-C50.2

ICD-O-3

Lobular carcinoma, NOS, of upper-inner quadrant of breast

+∞

31.7

C18.20

ICD-10 Finland

Malignant tumor of the ascending colon without histology

+∞

31.7

YL1AD

NOMESCO Finland

CT examination of pelvis for dose design of radiotherapy

+∞

31.7

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

2.6

31.5

183

674

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.7

31.5

642

3746

JFB31

NOMESCO Finland

Laparoscopic right hemicolectomy

6.5

31.4

JN3KE

NOMESCO Finland

Abdominal ultrasound with added contrast

8.5

31.4

C57.0

ICD-10 Finland

Malignant neoplasm: Fallopian tube

303.1

31.3

HA4BT

NOMESCO Finland

Breast seed implant placement under ultrasound guidance

157.7

31.1

8097/3-C44.9

ICD-O-3

Basal cell carcinoma, nodular of skin, NOS

+∞

30.7

8211/3-C50.4

ICD-O-3

Tubular adenocarcinoma of upper-outer quadrant of breast

+∞

30.7

8720/3-C44.7

ICD-O-3

Malignant melanoma, NOS, of skin of lower limb and hip

+∞

30.7

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

1.8

30.6

492

2686

T81.8

ICD-10 Finland

Other complications of procedures, not elsewhere classified

2.7

30.5

172

624

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

1.9

30.5

418

2172

Z2221

NOMESCO Finland

Medical doctor

1.3

30.5

2291

17291

GA4AT

NOMESCO Finland

Cathetrisation of pleural cavity with ultrasound guidance

4.4

30.4

164

D70.89

ICD-10 Finland

Neutropenic splenomegaly

3.7

30.4

247

SPAT1324

SPAT

Screening procedure

0.7

30.4

1066

14247

ZX050

NOMESCO Finland

Stereotactic radiotherapy

10.9

30.0

C79.39

ICD-10 Finland

Secondary malignant tumor of the meninges, ventricle or other part of the brain

+∞

29.7

1XC13, ,

NOMESCO Finland

+∞

29.7

PJD63

NOMESCO Finland

Laparoscopic dissection of aortic lymph nodes

288.8

29.2

C57.9

ICD-10 Finland

Malignant neoplasm: Female genital organ, unspecified

288.8

29.2

9708

FHL

Radical mastectomy (Halsted), also involves removal of the parasternal gland

288.8

29.2

WC105

NOMESCO Finland

Simple cytostatic therapy of local tumor recidive

288.8

29.2

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

2.5

28.8

180

688

8140/3-C18.2

ICD-O-3

Adenocarcinoma, NOS, of ascending colon

+∞

28.6

WF001

NOMESCO Finland

Preoperative radiotherapy

+∞

28.6

8500/2-C50.5

ICD-O-3

Intraductal carcinoma, noninfiltrating, NOS, of lower-outer quadrant of breast

+∞

28.6

8720/3-C44.5

ICD-O-3

Malignant melanoma, NOS, of skin of trunk

+∞

28.6

WB131

NOMESCO Finland

Very demanding neoadjuvant cytostatic therapy

+∞

28.6

XX2ET, ,

NOMESCO Finland

+∞

28.6

QB9S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in torso, unspecified

5.5

28.5

ZSZ10

NOMESCO Finland

Secondary repair operation

54.1

28.4

D48.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Skin

1.8

28.4

430

2305

M05BA02

ATC

clodronic acid; systemic

30.3

28.3

C85.9

ICD-10 Finland

Non-Hodgkin lymphoma, unspecified

278.8

28.2

AAG50

NOMESCO Finland

Stereotactic intracranial radiotherapy

7.9

28.2

6117B

ICD-9 Finland

Other disorders of breast, Signs and symptoms in breast[TUMOR MAMMAE]

3.7

28.0

226

Z80.8

ICD-10 Finland

Family history of malignant neoplasm of other organs or systems

7.2

27.9

TPX15

NOMESCO Finland

Removal of vascular injection port

9.3

27.7

LAF16

NOMESCO Finland

Excision of uterus, adnexes and lymph nodes for treatment of ovarian cancer

34.4

27.6

C34.10

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung without histology

+∞

27.6

C34.90

ICD-10 Finland

Malignant tumor in unspecified location in bronchus and lung without histology

+∞

27.6

8140/3-C34.1

ICD-O-3

Adenocarcinoma, NOS, of upper lobe, lung

+∞

27.6

8500/2-C50.3

ICD-O-3

Intraductal carcinoma, noninfiltrating, NOS, of lower-inner quadrant of breast

+∞

27.6

N05CF01

ATC

zopiclone; oral

1.3

27.6

3048

24192

THA00

NOMESCO Finland

Needle biopsy of mamilla

8.4

27.2

A06AH03

ATC

naloxegol; oral

4.6

27.1

136

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.6

26.9

658

4015

I89.0

ICD-10 Finland

Lymphoedema, not elsewhere classified

3.6

26.8

237

KCD02

NOMESCO Finland

Transurethral resection of bladder

6.1

26.7

C56.98

ICD-10 Finland

Malignant tumor of the ovary, indeterminate histology

+∞

26.6

C49.39

ICD-10 Finland

Malignant tumor of connective tissue and soft tissue of the thorax other or unspecified tumor

+∞

26.6

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.6

26.4

593

3543

HA1AT, ,

SPAT

8.4

26.4

A46

ICD-10 Finland

Erysipelas

1.4

26.2

1062

7217

HA5CB

NOMESCO Finland

Galactography

5.9

26.0

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.6

25.9

587

3516

I80.8

ICD-10 Finland

Phlebitis and thrombophlebitis of other sites

2.8

25.9

129

440

NK6AQ

NOMESCO Finland

Whole body bone SPET with low dose CT

23.6

25.8

8522/3-C50.9

ICD-O-3

Infiltrating duct and lobular carcinoma of breast, NOS

+∞

25.6

C507, ,

ICD-10 Finland

+∞

25.6

C78.2

ICD-10 Finland

Secondary malignant neoplasm of pleura

+∞

25.6

8401/3-C50.9

ICD-O-3

Apocrine adenocarcinoma of breast, NOS

+∞

25.6

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.4

25.5

1554

11319

TQW11

NOMESCO Finland

Vacuum treatment of wound

2.5

25.4

158

603

YA1VG

NOMESCO Finland

MRI examination of head and neck with high intesity magnet for dose design of radiotherapy

10.3

25.4

QX3AT

NOMESCO Finland

Ultrasound guided biopsy of subcutaneous tissue

6.2

25.1

D41.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Kidney

2.9

24.9

115

376

9729

FHL

Other measure in this category

5.4

24.7

8500/2-C50.2

ICD-O-3

Intraductal carcinoma, noninfiltrating, NOS, of upper-inner quadrant of breast

+∞

24.5

C83.3

ICD-10 Finland

Diffuse large B-cell lymphoma

+∞

24.5

ZZQ70

NOMESCO Finland

Free microvascular graft of lymph nodes

+∞

24.5

8070/3-C44.3

ICD-O-3

Squamous cell carcinoma, NOS, of skin of other and unspecified parts of face

+∞

24.5

8543/3-C50.9

ICD-O-3

Paget disease and intraductal carcinoma of breast of breast, NOS

+∞

24.5

8140/3-C34.9

ICD-O-3

Adenocarcinoma, NOS, of lung, NOS

+∞

24.5

C50.61

ICD-10 Finland

Malignant tumor of the scapula of the mammary gland, ductal tumor

+∞

24.5

M05BX04

ATC

denosumab; parenteral

1.6

24.5

586

3555

WX400

NOMESCO Finland

Inhalation anesthesy

1.9

24.4

313

1593

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.5

24.2

723

4616

QBE00

NOMESCO Finland

Excision of loose skin or fold of skin from trunk

4.7

23.9

115

QBA10

NOMESCO Finland

Incision of skin of trunk

3.5

23.8

220

N95.1

ICD-10 Finland

Menopausal and female climacteric states

0.7

23.6

762

10400

L90.5

ICD-10 Finland

Scar conditions and fibrosis of skin

3.2

23.6

292

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

1.9

23.6

303

1544

C77.1

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes

+∞

23.5

L01AX03

ATC

temozolomide; systemic

+∞

23.5

8120/3-C67.9

ICD-O-3

Transitional cell carcinoma, NOS, of bladder, NOS

+∞

23.5

C85.1

ICD-10 Finland

B-cell lymphoma, unspecified

+∞

23.5

8523/3-C50.9

ICD-O-3

Infiltrating duct mixed with other types of carcinoma of breast, NOS

+∞

23.5

L01CB01

ATC

etoposide; systemic

+∞

23.5

C83.80

ICD-10 Finland

B-cell lymphoma in marginal zone

+∞

23.5

8312/3-C64.9

ICD-O-3

Renal cell carcinoma, NOS, of kidney, NOS

+∞

23.5

PJA01

NOMESCO Finland

Laparoscopic sentinel node excision

64.4

23.3

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.5

23.2

879

5888

C20.92

ICD-10 Finland

Malignant tumor of the rectum carcinoma of the adenoma

229.1

23.2

C54.10

ICD-10 Finland

Malignant tumor of endometrium without histology

229.1

23.2

ZQZ00

NOMESCO Finland

Treatment of several skin areas

7.1

23.1

X77

ICPC

Malignant neopl genital female other

39.5

23.0

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

3.5

22.9

212

Y83.8

ICD-10 Finland

Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.1

22.7

212

964

PJ5YQ, ,

NOMESCO Finland

+∞

22.5

C77.8

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions

+∞

22.5

8575/3-C50.9

ICD-O-3

Metaplastic carcinoma, NOS, of breast, NOS

+∞

22.5

YN7BD

NOMESCO Finland

Extensive CT examination of spine for dose design of radiotherapy

+∞

22.5

D37.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other digestive organs

2.4

22.2

157

636

C34.9

ICD-10 Finland

Malignant neoplasm: Bronchus or lung, unspecified

219.5

22.2

C43.52

ICD-10 Finland

Malignant melanoma on the torso: 'superficial spreading' type

219.5

22.2

XX9AQ

NOMESCO Finland

Supplementary SPECT-CT or additional scan

114.6

22.1

PJ2AE

NOMESCO Finland

Lymphnode ultrasound examination

4.4

22.0

123

L02AE02

ATC

leuprorelin; implant, parenteral

3.2

22.0

265

R22.2

ICD-10 Finland

Localized swelling, mass and lump, trunk

1.9

21.9

272

1371

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

3.3

21.5

230

C44.81

ICD-10 Finland

Overall basocellular carcinoma of the skin

+∞

21.5

C34.11

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma

+∞

21.5

8090/3-C44.6

ICD-O-3

Basal cell carcinoma, NOS, of skin of upper limb and shoulder

+∞

21.5

C54.1

ICD-10 Finland

Malignant neoplasm: Endometrium

210.0

21.2

C20.99

ICD-10 Finland

Malignant tumor of the rectum other or unspecified histology

109.8

21.1

J94.8

ICD-10 Finland

Other specified pleural conditions

3.2

21.0

258

HAD55

NOMESCO Finland

Incision of periprosthetic capsule of breast

29.7

20.9

N60.1

ICD-10 Finland

Diffuse cystic mastopathy

2.8

20.8

103

351

WD315

NOMESCO Finland

Multiple therapy of methastized malignancy with biomodifiers

25.2

20.8

D41.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Bladder

4.6

20.6

102

QX3HE

NOMESCO Finland

Ultrsound examination of lesion close to skin

2.7

20.5

109

385

ZXC96

NOMESCO Finland

Robot assisted procedure

3.3

20.5

228

9020/3-C50.9

ICD-O-3

Phyllodes tumor, malignant of breast, NOS

+∞

20.5

YX9CD

NOMESCO Finland

Other very extensive CT eamination for dose design of radiotherapy

+∞

20.5

8720/3-C44.9

ICD-O-3

Malignant melanoma, NOS, of skin, NOS

+∞

20.5

8140/3-C34.3

ICD-O-3

Adenocarcinoma, NOS, of lower lobe, lung

+∞

20.5

C83.9

ICD-10 Finland

Non-follicular (diffuse) lymphoma, unspecified

+∞

20.5

8461/3-C57.0

ICD-O-3

High grade serous carcinoma of fallopian tube

+∞

20.5

2170A

ICD-9 Finland

Benign neoplasm of breast[NEOPLASMA BENIGNUM MAMMAE]

3.0

20.4

277

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.6

20.3

496

3024

C92.0

ICD-10 Finland

Acute myeloblastic leukaemia [AML]

200.4

20.2

C43.72

ICD-10 Finland

Malignant melanoma of the lower extremity including the hip: 'superficial spreading' type

200.4

20.2

C19

ICD-10 Finland

Malignant neoplasm of rectosigmoid junction

200.4

20.2

QWF00

NOMESCO Finland

Reoperation for insufficiency of suture in plastic surgery of skin

105.0

20.1

Z08.8

ICD-10 Finland

Follow-up examination after other treatment for malignant neoplasm

28.6

20.0

C44.72

ICD-10 Finland

Spinocellular carcinoma of the skin of the lower extremity including the hip

39.7

19.9

ZXE50

NOMESCO Finland

More than nine and less than 12 hours

3.0

19.8

267

A08

ICPC

Swelling

1.6

19.8

456

2742

ZZA50

NOMESCO Finland

Full thickness skin graft

8.1

19.8

PJ4AT

NOMESCO Finland

Labeling lymphnode with ultrasound guidance

54.9

19.4

C34.3

ICD-10 Finland

Malignant neoplasm: Lower lobe, bronchus or lung

+∞

19.4

C79.2

ICD-10 Finland

Secondary malignant neoplasm of skin

+∞

19.4

YJ2VG

NOMESCO Finland

MRI examination of pelvis with high intensity magnet for dose design of radiotherapy

+∞

19.4

335

Kela drug reimbursment

Lapatinib

+∞

19.4

C17.9

ICD-10 Finland

Malignant neoplasm: Small intestine, unspecified

+∞

19.4

X79

ICPC

Benign neoplasm breast female

16.4

19.4

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.6

19.3

417

2469

9823/3-C42.1

ICD-O-3

B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow

70.1

19.3

C82.9

ICD-10 Finland

Follicular lymphoma, unspecified

190.8

19.2

ZZS55

NOMESCO Finland

Distension of tissue expander

100.2

19.2

JN4JR

NOMESCO Finland

Whole body extensive metabolic PET with CT

6.4

19.1

HA1DM

NOMESCO Finland

Mammary gland very extensive MRI examination with 3 Tesla magnet

38.1

19.0

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

2.2

19.0

163

718

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

0.8

18.9

5970

61182

QCE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in upper limb

2.2

18.8

152

654

JAL00

NOMESCO Finland

Biopsy of peritoneum

5.0

18.7

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.5

18.5

702

4700

8401/3-C50.4

ICD-O-3

Apocrine adenocarcinoma of upper-outer quadrant of breast

+∞

18.4

8530/3-C50.9

ICD-O-3

Inflammatory carcinoma of breast, NOS

+∞

18.4

WB600

NOMESCO Finland

Neoadjuvant therapy of primary tumour with antibodies

+∞

18.4

8140/3-C18.9

ICD-O-3

Adenocarcinoma, NOS, of colon, NOS

+∞

18.4

8000/3-C25.9

ICD-O-3

Neoplasm, malignant of pancreas, NOS

+∞

18.4

C82.01

ICD-10 Finland

Follicular nodular lymphoma, grade I

+∞

18.4

1930A

ICD-9 Finland

Malignant neoplasm of thyroid gland[CARCINOMA PAPILLARE THYREOIDEAE]

+∞

18.4

8211/3-C50.2

ICD-O-3

Tubular adenocarcinoma of upper-inner quadrant of breast

+∞

18.4

ZZA00

NOMESCO Finland

Split skin graft

2.2

18.4

155

678

XW000

NOMESCO Finland

Bone marrow biopsy

2.0

18.4

199

958

X18

ICPC

Breast pain female

2.1

18.2

163

731

C16.9

ICD-10 Finland

Malignant neoplasm: Stomach, unspecified

181.3

18.2

WW200, ,

SPAT

0.8

18.1

1395

16634

HA1RA, ,

SPAT

1.5

18.0

504

3172

T81.9

ICD-10 Finland

Unspecified complication of procedure

2.3

18.0

136

569

D75

ICPC

Malignant neoplasm colon/rectum

14.3

17.8

R84

ICPC

Malignant neoplasm bronchus/lung

42.0

17.8

A21

ICPC

Risk factor for malignancy

23.9

17.7

QDE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in lower limb

2.0

17.7

189

906

CBB50

NOMESCO Finland

Excision of lesion of eyelid and reconstruction using graft or flap

50.1

17.5

9732/3-C42.1

ICD-O-3

Plasma cell myeloma of bone marrow

50.1

17.5

C54.9

ICD-10 Finland

Malignant neoplasm: Corpus uteri, unspecified

+∞

17.4

C18.31

ICD-10 Finland

Malignant tumor of flexura hepatica invasive carcinoma

+∞

17.4

C34.99

ICD-10 Finland

Malignant tumor in unspecified localization in bronchial and pulmonary other or unspecified histology

+∞

17.4

8140/3-C18.0

ICD-O-3

Adenocarcinoma, NOS, of cecum

+∞

17.4

JN5PN

NOMESCO Finland

Isotope imaging of secondary neoplasms of thyroid origin

+∞

17.4

8480/3-C50.4

ICD-O-3

Mucinous adenocarcinoma of upper-outer quadrant of breast

+∞

17.4

C15.5

ICD-10 Finland

Malignant neoplasm: Lower third of oesophagus

+∞

17.4

1CD01, ,

NOMESCO Finland

+∞

17.4

8720/3-C44.6

ICD-O-3

Malignant melanoma, NOS, of skin of upper limb and shoulder

+∞

17.4

L04AX04

ATC

lenalidomide; oral

+∞

17.4

8523/3-C50.4

ICD-O-3

Infiltrating duct mixed with other types of carcinoma of upper-outer quadrant of breast

+∞

17.4

C53.01

ICD-10 Finland

Squamous cell carcinoma of the endocervix

+∞

17.4

8522/3-C50.4

ICD-O-3

Infiltrating duct and lobular carcinoma of upper-outer quadrant of breast

+∞

17.4

8441/3-C56.9

ICD-O-3

Serous carcinoma, NOS, of ovary

+∞

17.4

C50.02

ICD-10 Finland

Malignant tumor of nipple and areola, lobular tumor

+∞

17.4

C80.99

ICD-10 Finland

Malignant tumor without specified localization or histology

+∞

17.4

ZZS50

NOMESCO Finland

Insertion of tissue expander

90.7

17.2

C44.39

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face other or unspecified histology

35.0

17.2

C05.1

ICD-10 Finland

Malignant neoplasm: Soft palate

171.7

17.2

153

Kela drug reimbursment

Lenalidomid

171.7

17.2

JAQ00

NOMESCO Finland

Extensive excision of peritoneum

171.7

17.2

HAF00

NOMESCO Finland

Excision of local recurrence of breast cancer

171.7

17.2

N60.0

ICD-10 Finland

Solitary cyst of breast

2.9

16.9

261

L02AB02

ATC

medroxyprogesterone; systemic

3.5

16.7

160

HAB30

NOMESCO Finland

Excision of mamilla or areola

18.4

16.4

8575/3-C50.4

ICD-O-3

Metaplastic carcinoma, NOS, of upper-outer quadrant of breast

+∞

16.4

1511

Kela drug reimbursment

Olaparib

+∞

16.4

C77.2

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes

+∞

16.4

C18.7

ICD-10 Finland

Malignant neoplasm: Sigmoid colon

+∞

16.4

389

Kela drug reimbursment

Olaparib

+∞

16.4

C18.2

ICD-10 Finland

Malignant neoplasm: Ascending colon

+∞

16.4

8520/3-C50.5

ICD-O-3

Lobular carcinoma, NOS, of lower-outer quadrant of breast

+∞

16.4

C43.50

ICD-10 Finland

Malignant melanoma of the torso without histology

+∞

16.4

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

1.6

16.3

364

2172

ZXC90

NOMESCO Finland

Use of absorbable mesh in surgery

85.9

16.2

HAC99

NOMESCO Finland

Other mastectomy

162.2

16.2

D04.3

ICD-10 Finland

Carcinoma in situ: Skin of other and unspecified parts of face

2.3

16.2

117

481

LCD01

NOMESCO Finland

Total laparoscopic hysterectomy

2.0

16.0

174

839

GDC00

NOMESCO Finland

Lobectomy of lung

19.1

15.9

D77

ICPC

Malignant digestive neopl other/NOS

38.1

15.9

N05BA04

ATC

oxazepam; oral

1.2

15.7

2356

19118

GD5AD

NOMESCO Finland

Thorax and upper abdomen combined CT examination of

2.8

15.6

273

GAA10

NOMESCO Finland

Intercostal insertion of pleural drainage tube

2.8

15.5

258

JAH00

NOMESCO Finland

Laparotomy

2.1

15.5

151

701

C43.62

ICD-10 Finland

Malignant melanoma of upper extremity including shoulder: 'superficial spreading' type

57.2

15.4

E0000UV, ,

ATC

1.2

15.4

3628

30738

ZX092, ,

NOMESCO Finland

+∞

15.3

C80.92

ICD-10 Finland

Malignant tumor without specified localization adenocarcinoma

+∞

15.3

C34.30

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung without histology

+∞

15.3

C67.2

ICD-10 Finland

Malignant neoplasm: Lateral wall of bladder

+∞

15.3

8090/3-C44.7

ICD-O-3

Basal cell carcinoma, NOS, of skin of lower limb and hip

+∞

15.3

8510/3-C50.4

ICD-O-3

Medullary carcinoma, NOS, of upper-outer quadrant of breast

+∞

15.3

JN5AN

NOMESCO Finland

Total body isotope imaging

+∞

15.3

WB323

NOMESCO Finland

Demanding adjuvant therapy of malignancy with biomodifiers

+∞

15.3

8500/2-C50.1

ICD-O-3

Intraductal carcinoma, noninfiltrating, NOS, of central portion of breast

+∞

15.3

C02.11

ICD-10 Finland

Malignant neoplasm of border of tongue

+∞

15.3

N05BA06

ATC

lorazepam; systemic, sublingual

1.6

15.3

382

2343

PG1BD

NOMESCO Finland

Extensive CT angiography of tissue graft, e.g. assessment of TRAN graft

81.2

15.2

C44.10

ICD-10 Finland

Malignant tumor of the skin of the eyelids including the corner of the eye without histology

81.2

15.2

C73

ICD-10 Finland

Malignant neoplasm of thyroid gland

152.6

15.2

C67.9

ICD-10 Finland

Malignant neoplasm: Bladder, unspecified

152.6

15.2

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.5

15.2

567

3786

B01AB04

ATC

dalteparin; parenteral

1.6

15.2

366

2228

TPW99

NOMESCO Finland

Other minor surgical procedure on peripheral vessel or lymphatic system

3.1

15.1

186

N02AA01

ATC

morphine; systemic, rectal

2.6

15.0

317

C44.50

ICD-10 Finland

Malignant tumor of the skin on the torso without histology

36.3

15.0

JFF23

NOMESCO Finland

Transversostomy

4.4

14.9

9722

FHL

Reduction plastic and possible mamilla transposition

3.8

14.9

113

WX725

NOMESCO Finland

Noninvasive ventilation

1.6

14.9

351

2125

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

2.2

14.8

129

573

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.3

14.8

1684

13250

YX8BD

NOMESCO Finland

Stereotactic extensive CT examination for dose design of radiotherapy

16.9

14.7

GA5AA

NOMESCO Finland

Rib X-ray examination

4.7

14.4

G03FA14

ATC

dydrogesterone and estrogen; systemic

0.7

14.4

416

5820

215

Kela drug reimbursment

Diabetes, non-insulin-treated

0.8

14.3

1267

14898

C18.29

ICD-10 Finland

Malignant tumor of the ascending colon or other unspecified histology

+∞

14.3

L01EF03

ATC

abemaciclib; oral

+∞

14.3

ZX040

NOMESCO Finland

Intracavity HDR radiotherapy

+∞

14.3

1XC14, ,

NOMESCO Finland

+∞

14.3

C79.3

ICD-10 Finland

Secondary malignant neoplasm of brain and cerebral meninges

+∞

14.3

C34.22

ICD-10 Finland

Malignant tumor of the middle lobe, bronchus or lung adenocarcinoma

+∞

14.3

9680/3-C50.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of breast, NOS

+∞

14.3

C34.82

ICD-10 Finland

Malignant overall tumor of bronchial and pulmonary adenocarcinoma

+∞

14.3

C83.39

ICD-10 Finland

Diffuse non-Hodgkin's large cell lymphoma UNS

+∞

14.3

PJD53

NOMESCO Finland

Block dissection of aortic lymph nodes

+∞

14.3

L01XK01

ATC

olaparib; oral

+∞

14.3

8097/3-C44.3

ICD-O-3

Basal cell carcinoma, nodular of skin of other and unspecified parts of face

+∞

14.3

C54.14

ICD-10 Finland

Serous papillary carcinoma of the endometrium

+∞

14.3

8504/2-C50.9

ICD-O-3

Encapsulated papillary carcinoma of breast, NOS

+∞

14.3

C34.92

ICD-10 Finland

Malignant tumor in unspecified localization in bronchial and pulmonary adenocarcinoma

+∞

14.3

C18.11

ICD-10 Finland

Malignant tumor of the appendix invasive carcinoma

+∞

14.3

C73.90

ICD-10 Finland

Malignant tumor of the thyroid gland (thyroid gland) without histology

+∞

14.3

1744A, ,

ICD-10 Finland

+∞

14.3

103

Kela drug reimbursment

Diabetes, insulin-treated

0.8

14.3

1420

16466

JGB06

NOMESCO Finland

Partial proctectomy with total excision of mesorectum

76.4

14.3

C22.9

ICD-10 Finland

Malignant neoplasm: Liver, unspecified

143.1

14.2

YN7AD

NOMESCO Finland

CT examination of spine for dose design of radiotherapy

143.1

14.2

JGB07

NOMESCO Finland

Laparoscopic partial proctectomy with total excision of mesorectum

34.3

14.1

GAA96

NOMESCO Finland

Other open or percutaneous drainage of pleural cavity

6.0

14.0

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

1.6

13.9

302

1793

GD5BD

NOMESCO Finland

Thorax and upper abdomen combined extensive CT examination of

2.4

13.9

399

HAD57

NOMESCO Finland

Resection of periprosthetic capsule of breast

18.2

13.8

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.3

13.7

1275

9788

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.2

13.7

1688

13389

QAA05

NOMESCO Finland

Incision for biopsy of skin of head or neck

2.2

13.7

119

529

JFF10

NOMESCO Finland

Loop enterostomy

5.0

13.7

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.2

13.6

2361

19391

QWD00

NOMESCO Finland

Reoperation for superficial haemorrhage in surgery of skin

4.9

13.6

C64

ICD-10 Finland

Malignant neoplasm of kidney, except renal pelvis

50.9

13.5

ZZR70

NOMESCO Finland

Perforator flaps

50.9

13.5

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.3

13.4

925

6829

C81.1

ICD-10 Finland

Nodular sclerosis classical Hodgkin lymphoma

+∞

13.3

9680/3-C77.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of lymph node, NOS

+∞

13.3

C56.92

ICD-10 Finland

Malignant ovarian tumor, sex chord stroma derived

+∞

13.3

C83.00

ICD-10 Finland

Lymphocytic lymphoma

+∞

13.3

C53.02

ICD-10 Finland

Adenocarcinoma of the endocervix

+∞

13.3

C34.31

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung epidermoid carcinoma

+∞

13.3

C49.30

ICD-10 Finland

Malignant tumor of connective tissue and soft tissue of the thorax without histology

+∞

13.3

8140/3-C19.9

ICD-O-3

Adenocarcinoma, NOS, of rectosigmoid junction

+∞

13.3

C25.1

ICD-10 Finland

Malignant neoplasm: Body of pancreas

+∞

13.3

C81.9

ICD-10 Finland

Hodgkin lymphoma, unspecified

+∞

13.3

8520/3-C50.1

ICD-O-3

Lobular carcinoma, NOS, of central portion of breast

+∞

13.3

C51.81

ICD-10 Finland

Squamous cell carcinoma of the vulva

+∞

13.3

8620/3-C56.9

ICD-O-3

Adult granulosa cell tumor of ovary of ovary

+∞

13.3

C56.73

ICD-10 Finland

Endomeroid epithelial carcinoma of the ovary

+∞

13.3

WD515

NOMESCO Finland

Demanding therapy of malignancy with enzyme inhibitors and similar treatments

71.6

13.3

JFG10

NOMESCO Finland

Closure of loop colostomy without resection

3.9

13.3

SPAT1153

SPAT

Removal of sutures

1.2

13.2

2474

20456

329

Kela drug reimbursment

Lenalidomide

133.5

13.2

C43.70

ICD-10 Finland

Malignant melanoma of the lower extremity including the hip without histology

133.5

13.2

C15.9

ICD-10 Finland

Malignant neoplasm: Oesophagus, unspecified

133.5

13.2

C18.90

ICD-10 Finland

Malignant tumor in unspecified location in the colon without histology

133.5

13.2

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.4

13.1

548

3734

A10BA02

ATC

metformin; oral

0.8

12.9

1566

17795

L82

ICD-10 Finland

Seborrhoeic keratosis

1.2

12.9

1579

12506

ZXA10

NOMESCO Finland

Bilateral

1.2

12.9

1627

12932

AAB10

NOMESCO Finland

Partial excision of intracranial lesion

3.5

12.8

121

C43.59

ICD-10 Finland

Malignant melanoma of the trunk other or unspecified histology

38.1

12.8

QBE35

NOMESCO Finland

Repair of skin defect in trunk after surgery or injury

10.4

12.6

PJD81

NOMESCO Finland

Excision of lymph nodes from upper part of neck

21.5

12.5

QCJ00

NOMESCO Finland

Liposuction in upper limb

18.1

12.5

ZX121

NOMESCO Finland

Central venous catheter

9.5

12.5

XX9BW

NOMESCO Finland

Submitting image material and/or investigation material to authority or other institution

2.5

12.4

308

PJD71

NOMESCO Finland

Extended sparing excision of cervical lymph nodes

66.6

12.3

C21.1

ICD-10 Finland

Malignant neoplasm: Anal canal

+∞

12.3

ZX095

NOMESCO Finland

Combined chemoradiotherapy

+∞

12.3

C54.19

ICD-10 Finland

Malignant tumor of endometrium, unspecified histology

+∞

12.3

C80.90

ICD-10 Finland

Malignant tumor without specified localization without histology

+∞

12.3

C34.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bronchus and lung

+∞

12.3

C56.79

ICD-10 Finland

Other epithelial carcinoma of the ovary

+∞

12.3

LE090

NOMESCO Finland

Profylactive radiotherapy of vulva and vagina

+∞

12.3

C26.9

ICD-10 Finland

Malignant neoplasm: Ill-defined sites within the digestive system

+∞

12.3

8500/2-C50.8

ICD-O-3

Intraductal carcinoma, noninfiltrating, NOS, of overlapping lesion of breast

+∞

12.3

ZZQ60

NOMESCO Finland

Free microvascular graft of nerve

+∞

12.3

C56.72

ICD-10 Finland

Mucinous epithelial carcinoma of the ovary

+∞

12.3

C50.69

ICD-10 Finland

Malignant tumor of the scapula of the mammary gland, other or undeterminated histology

+∞

12.3

C18.72

ICD-10 Finland

Malignant tumor of sigmoid carcinoma of adenoma

+∞

12.3

1501

Kela drug reimbursment

Palbociclib

+∞

12.3

Z44.3

ICD-10 Finland

Fitting and adjustment of external breast prosthesis

+∞

12.3

394

Kela drug reimbursment

Palbociclib

+∞

12.3

8543/3-C50.1

ICD-O-3

Paget disease and intraductal carcinoma of breast of central portion of breast

+∞

12.3

8140/3-C16.9

ICD-O-3

Adenocarcinoma, NOS, of stomach, NOS

+∞

12.3

8520/3-C50.8

ICD-O-3

Lobular carcinoma, NOS, of overlapping lesion of breast

+∞

12.3

C18.79

ICD-10 Finland

Malignant tumor of the sigmoid or other unspecified histology

+∞

12.3

C78.8

ICD-10 Finland

Secondary malignant neoplasm of other and unspecified digestive organs

+∞

12.3

ZSP00

NOMESCO Finland

Procedure related to previous procedure classified in chapter P

30.5

12.3

Z2446

NOMESCO Finland

Social worker

1.5

12.2

373

2395

C73.92

ICD-10 Finland

Follicular carcinoma of the thyroid gland

124.0

12.2

C22.1

ICD-10 Finland

Malignant neoplasm: Intrahepatic bile duct carcinoma

124.0

12.2

SAA01

NOMESCO Finland

Simple examination of mouth

0.9

12.1

5578

56630

JA2AT

NOMESCO Finland

Abdominal puncture with ultrasound guidance

3.2

12.1

140

R06AE07

ATC

cetirizine; oral

1.2

12.1

4037

34992

L03AB05

ATC

interferon alfa-2b; parenteral

5.0

12.1

JN3AD

NOMESCO Finland

Abdominal CT examination

1.3

12.0

716

5171

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

2.1

12.0

114

525

T90

ICPC

Diabetes non-insulin dependent

0.8

12.0

1281

14772

KCD05

NOMESCO Finland

Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)

12.5

12.0

C44.91

ICD-10 Finland

Unspecified localization of basocellular carcinoma of the skin

8.8

12.0

D22.5

ICD-10 Finland

Melanocytic naevi of trunk

1.5

11.9

346

2198

C43.79

ICD-10 Finland

Malignant melanoma of the lower extremity including hip or other unspecified histology

35.8

11.9

JG1BG

NOMESCO Finland

MRI of rectum

11.0

11.9

TJF80

NOMESCO Finland

Ostomy education

3.4

11.8

114

LX1XE

NOMESCO Finland

Other gynecological ultrasound examination

1.6

11.7

238

1391

ZXC82

NOMESCO Finland

Microsurgical

17.2

11.7

XW3AT

NOMESCO Finland

Biopsy of other superficial organ with ultrasound guidance

4.3

11.7

E34.0

ICD-10 Finland

Carcinoid syndrome

44.5

11.6

A26

ICPC

Fear of cancer, NOS

3.0

11.6

164

ZXD05

NOMESCO Finland

Urgent procedure

1.2

11.5

2133

17589

QBJ99

NOMESCO Finland

Other aesthetic correction of skin of trunk

13.9

11.4

EN1BD

NOMESCO Finland

Very extensive CT examination of mouth and soft tissues of neck

2.5

11.4

274

QBA99

NOMESCO Finland

Other local destruction of skin of trunk

2.9

11.4

171

YX8VG

NOMESCO Finland

Stereotactic MRI exmaination with high intensity magnet for dose design of radiotherapy

28.6

11.3

SPAT1152

SPAT

Removal of foreign body from under the skin

1.7

11.3

191

1063

9705

FHL

Subcutaneous mastectomy

15.6

11.3

D37.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Colon

2.5

11.3

275

C82.00

ICD-10 Finland

Follicular nodular non-Hodgkin's lymphoma, ungraded

+∞

11.2

8522/3-C50.5

ICD-O-3

Infiltrating duct and lobular carcinoma of lower-outer quadrant of breast

+∞

11.2

8070/3-C53.9

ICD-O-3

Squamous cell carcinoma, NOS, of cervix uteri

+∞

11.2

C73.99

ICD-10 Finland

Malignant tumor of the thyroid gland (thyroid gland), other or unspecified histology

+∞

11.2

C18.99

ICD-10 Finland

Malignant tumor in unspecified location in the colon other or unspecified histology

+∞

11.2

180

Kela drug reimbursment

Interferon alfa

+∞

11.2

C77.4

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Inguinal and lower limb lymph nodes

+∞

11.2

1830A

ICD-9 Finland

Malignant neoplasm of ovary and other uterine adnexa, Ovary

+∞

11.2

8540/3-C50.0

ICD-O-3

Paget disease, mammary of nipple

+∞

11.2

WC115

NOMESCO Finland

Cytostatic therapy of local tumor recidive with multiple drugs

+∞

11.2

C18.61

ICD-10 Finland

Malignant tumor of the colon descending invasive carcinoma

+∞

11.2

C739, ,

ICD-10 Finland

+∞

11.2

PJ2D3

NOMESCO Finland

Histological assessment of lymph node

+∞

11.2

C18.41

ICD-10 Finland

Malignant tumor of the transverse colon invasive carcinoma

+∞

11.2

8090/3-C44.0

ICD-O-3

Basal cell carcinoma, NOS, of skin of lip, NOS

+∞

11.2

8140/3-C25.9

ICD-O-3

Adenocarcinoma, NOS, of pancreas, NOS

+∞

11.2

C69.30

ICD-10 Finland

Malignant tumor of the chorioidea without histology

+∞

11.2

C18.30

ICD-10 Finland

Malignant tumor of flexura hepatica without histology

+∞

11.2

C55

ICD-10 Finland

Malignant neoplasm of uterus, part unspecified

+∞

11.2

C82.2

ICD-10 Finland

Follicular lymphoma grade III, unspecified

+∞

11.2

8097/3-C44.5

ICD-O-3

Basal cell carcinoma, nodular of skin of trunk

+∞

11.2

C17.2

ICD-10 Finland

Malignant neoplasm: Ileum

114.4

11.2

C22.0

ICD-10 Finland

Malignant neoplasm: Liver cell carcinoma

114.4

11.2

HA1UA

NOMESCO Finland

Contrast-enhanced X-ray of the mammary gland

114.4

11.2

9710

FHL

Existence of a relapse

114.4

11.2

C43.99

ICD-10 Finland

Unspecified localization of malignant melanoma of the skin other or unspecified histology

114.4

11.2

ZXD20

NOMESCO Finland

Day surgery

1.3

11.1

1046

8034

J01CE08

ATC

benzathine benzylpenicillin; parenteral

2.4

11.0

290

WPA13

NOMESCO Finland

Palliative consultation

5.1

11.0

WX002

NOMESCO Finland

Sedation and analgesia

1.2

11.0

1550

12444

C44.62

ICD-10 Finland

Spinocellular carcinoma of the skin of the upper extremity including the shoulder

33.4

11.0

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

1.6

10.9

233

1379

Z80.0

ICD-10 Finland

Family history of malignant neoplasm of digestive organs

3.0

10.8

145

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

1.5

10.8

324

2074

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

2.1

10.7

101

465

WX707

NOMESCO Finland

Fiberoscopic intubation

5.1

10.6

TQW40

NOMESCO Finland

Remowal of suture of skin

1.4

10.5

506

3536

C44.21

ICD-10 Finland

Basocellular carcinoma of the skin of the outer ear and the outer ear canal

14.7

10.5

L02AE03

ATC

goserelin; implant

2.7

10.4

201

A98

ICPC

Health maint/preventive medicine

0.8

10.4

9024

87640

H01CB03

ATC

lanreotide; parenteral

17.0

10.4

C51.11

ICD-10 Finland

Squamous cell carcinoma of the labium minus

57.2

10.4

-1, ,

ICD-10 Finland

1.5

10.3

283

1777

HA4GT

NOMESCO Finland

Labeling mammary gland pathology with galactographic guidance

3.8

10.3

EP2AT

NOMESCO Finland

Neck soft tissue cytology with ultrasound guidance

5.0

10.3

NK6CT

NOMESCO Finland

Bone biopsy with CT guidance

5.0

10.3

A41.9

ICD-10 Finland

Sepsis, unspecified

1.7

10.3

186

1056

C26.0

ICD-10 Finland

Malignant neoplasm: Intestinal tract, part unspecified

+∞

10.2

C48.89

ICD-10 Finland

Overall malignant tumor of the peritoneum and retroperitoneum other or unspecified tumor

+∞

10.2

C83.1

ICD-10 Finland

Mantle cell lymphoma

+∞

10.2

C25.2

ICD-10 Finland

Malignant neoplasm: Tail of pancreas

+∞

10.2

C43.71

ICD-10 Finland

Malignant melanoma of the lower extremity including the hip originating in lentigo maligna

+∞

10.2

1515, ,

Kela drug reimbursment

+∞

10.2

C18.40

ICD-10 Finland

Malignant tumor of the transverse colon without histology

+∞

10.2

C34.00

ICD-10 Finland

Malignant tumor of the main bronchus without histology

+∞

10.2

8503/2-C50.4

ICD-O-3

Noninfiltrating intraductal papillary adenocarcinoma of upper-outer quadrant of breast

+∞

10.2

8070/3-C51.9

ICD-O-3

Squamous cell carcinoma, NOS, of vulva, NOS

+∞

10.2

C25.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of pancreas

+∞

10.2

9120/3-C50.9

ICD-O-3

Hemangiosarcoma of breast, NOS

+∞

10.2

C71.10

ICD-10 Finland

Malignant tumor in frontal lobe without histology

+∞

10.2

8441/3-C54.1

ICD-O-3

Serous carcinoma, NOS, of endometrium

+∞

10.2

C85.7

ICD-10 Finland

Other specified types of non-Hodgkin lymphoma

+∞

10.2

19399

ICD-8 Finland

Malignant neoplasm of thyroid gland

+∞

10.2

C71.90

ICD-10 Finland

Malignant tumor in unspecified localization in the brain without histology

+∞

10.2

8520/3-C50.3

ICD-O-3

Lobular carcinoma, NOS, of lower-inner quadrant of breast

+∞

10.2

8509/2-C50.9

ICD-O-3

Solid papillary carcinoma in situ of breast, NOS

+∞

10.2

8380/3-C56.9

ICD-O-3

Endometrioid adenocarcinoma, NOS, of ovary

+∞

10.2

8524/3-C50.9

ICD-O-3

Infiltrating lobular mixed with other types of carcinoma of breast, NOS

+∞

10.2

C18.09

ICD-10 Finland

Malignant tumor of caecum other or unspecified histology

+∞

10.2

8070/3-C34.1

ICD-O-3

Squamous cell carcinoma, NOS, of upper lobe, lung

+∞

10.2

WB501

NOMESCO Finland

Simple enzyme inhibitor or similar therapy of primary tumour

+∞

10.2

3030

Kela drug reimbursment

Abemaciclib

+∞

10.2

L01EH01

ATC

lapatinib; oral

+∞

10.2

C34.19

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung other or unspecified histology

+∞

10.2

1820A

ICD-9 Finland

Malignant neoplasm of body of uterus, Corpus uteri, except isthmus[CARCINOMA ENDOMETRII]

+∞

10.2

1BC02, ,

NOMESCO Finland

+∞

10.2

8130/2-C67.9

ICD-O-3

Papillary urothelial carcinoma, non-invasive of bladder, NOS

104.9

10.2

9829

FHL

Other measure in this category

104.9

10.2

D76

ICPC

Malignant neoplasm pancreas

104.9

10.2

QWA00

NOMESCO Finland

Repair of wound dehiscence in surgery of skin

3.3

10.2

111

A14AB01

ATC

nandrolone; parenteral

4.3

10.2

LAF10

NOMESCO Finland

Bilateral salpingo-oophorectomy

1.5

10.1

280

1763

J38.0

ICD-10 Finland

Paralysis of vocal cords and larynx

1.9

10.1

113

555

Z73.3

ICD-10 Finland

Stress, not elsewhere classified

2.0

10.0

100

471

JJB10

NOMESCO Finland

Atypcal resection of liver

22.3

10.0

Z03.1

ICD-10 Finland

Observation for suspected malignant neoplasm

2.7

9.9

190

A87

ICPC

Complication of medical treatment

2.6

9.9

207

XW1AT

NOMESCO Finland

Biopsy from other organ close to skin with ultrasound quidance

3.1

9.9

128

XX9KE

NOMESCO Finland

Ultrasound examination with contrast

12.5

9.8

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

1.7

9.8

158

870

C43.7

ICD-10 Finland

Malignant neoplasm: Malignant melanoma of lower limb, including hip

38.1

9.7

SAA02

NOMESCO Finland

Basic examination of mouth

0.9

9.7

5023

51004

R59.1

ICD-10 Finland

Generalized enlarged lymph nodes

2.5

9.7

237

2506

FHL

Thyroidectomy

5.2

9.7

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

1.7

9.7

175

995

PJD45

NOMESCO Finland

Excision of inguinal lymph nodes

8.0

9.7

C44

ICD-10 Finland

Other malignant neoplasms of skin

8.0

9.7

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.2

9.6

1096

8600

E66.01

ICD-10 Finland

Obesity due to excess calories

0.7

9.6

366

4865

QXE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in uspecified region

3.6

9.5

I10

ICD-10 Finland

Essential (primary) hypertension

0.9

9.5

4913

49915

C43.31

ICD-10 Finland

Malignant melanoma of another or unspecified part of the face originating in lentigo maligna

52.4

9.4

C15.4

ICD-10 Finland

Malignant neoplasm: Middle third of oesophagus

52.4

9.4

LC2DE

NOMESCO Finland

Demanding ultrsound examination of uterus, parametrium and lower part of abdomen with speciel methods

1.4

9.4

352

2358

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

0.8

9.3

660

8006

S04

ICPC

Lump/swelling localized

1.3

9.3

747

5626

SPAT1109

SPAT

Analgesia with portable analgesic pump

3.8

9.3

189

Kela drug reimbursment

Imatinib

95.4

9.2

C49.20

ICD-10 Finland

Malignant tumor of connective tissue and soft tissue of the lower extremity including the hip without histology

95.4

9.2

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

0.8

9.2

1314

14743

155

Kela drug reimbursment

Afatinib and gefitinib

+∞

9.2

C96.9

ICD-10 Finland

Malignant neoplasm of lymphoid, haematopoietic and related tissue, unspecified

+∞

9.2

C79.7

ICD-10 Finland

Secondary malignant neoplasm of adrenal gland

+∞

9.2

8330/3-C73.9

ICD-O-3

Follicular carcinoma, NOS, of thyroid gland

+∞

9.2

C92.1

ICD-10 Finland

Chronic myeloid leukaemia [CML], BCR/ABL-positive

+∞

9.2

1746A

ICD-9 Finland

Malignant neoplasm of female breast, Axillary tail

+∞

9.2

L01XE01

ATC

[U] imatinib

+∞

9.2

C44.99

ICD-10 Finland

Unspecified localization of malignant tumor in skin other or unspecified histology

+∞

9.2

C18.0

ICD-10 Finland

Malignant neoplasm: Caecum

+∞

9.2

WC401

NOMESCO Finland

Simple antibody therapy of local recurrence of tumour

+∞

9.2

4CJ01, ,

NOMESCO Finland

+∞

9.2

8070/3-C44.7

ICD-O-3

Squamous cell carcinoma, NOS, of skin of lower limb and hip

+∞

9.2

8000/3-C34.9

ICD-O-3

Neoplasm, malignant of lung, NOS

+∞

9.2

C17.0

ICD-10 Finland

Malignant neoplasm: Duodenum

+∞

9.2

C51.01

ICD-10 Finland

Squamous cell carcinoma of the labium majus

+∞

9.2

C34.16

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary microcellular carcinoma

+∞

9.2

XX7JT

NOMESCO Finland

Somatostatin isotope ablative therapy

+∞

9.2

8070/3-C15.9

ICD-O-3

Squamous cell carcinoma, NOS, of esophagus, NOS

+∞

9.2

H01CB02

ATC

octreotide; parenteral

9.5

9.2

N81.2

ICD-10 Finland

Incomplete uterovaginal prolapse

0.7

9.2

354

4698

N13.3

ICD-10 Finland

Other and unspecified hydronephrosis

2.1

9.2

403

Y69

ICD-10 Finland

Unspecified misadventure during surgical and medical care

2.2

9.2

334

D43.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Brain, supratentorial

3.9

9.1

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

1.5

9.1

311

2045

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

2.2

9.1

316

Y84.9

ICD-10 Finland

Medical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.0

9.1

124

KH1BT

NOMESCO Finland

Urinary tract cathetrisation with X-ray guidance

3.0

9.1

119

SFA10

NOMESCO Finland

One-surface restoration

0.9

9.1

3953

40673

KAC10

NOMESCO Finland

Total nephrectomy with capsule

7.6

9.0

A07AA02

ATC

nystatin; oral

1.3

9.0

498

3562

J05AB11

ATC

valaciclovir; oral

1.2

8.9

1174

9350

9734

FHL

Excision and local plastic or associated free skin grafting

2.7

8.9

163

D37.2

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Small intestine

3.7

8.8

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.3

8.8

781

5955

WF029

NOMESCO Finland

Radiotherapy of local residive tumor

14.8

8.8

SFA20

NOMESCO Finland

Two-surface restoration

0.9

8.7

4274

43692

PD2BD

NOMESCO Finland

Extensive CT angiography of pelvic organs

17.7

8.7

X20

ICPC

Nipple symptom/complaint female

3.2

8.6

103

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.1

8.6

4199

37077

XF400

NOMESCO Finland

ECG with 12 standard connections

1.2

8.5

1029

8122

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

1.4

8.5

328

2208

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

1.8

8.5

124

664

G62.0

ICD-10 Finland

Drug-induced polyneuropathy

10.2

8.5

HAA01

NOMESCO Finland

Suture of mammary gland

47.6

8.5

KAD01

NOMESCO Finland

Percutaneous endoscopic partial nephrectomy

6.5

8.5

ZXM40

NOMESCO Finland

Use of fluorescent substance

9.0

8.5

GD1AT

NOMESCO Finland

Biopsy of the lung with ultrasound guidance

9.0

8.5

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

2.2

8.4

302

M01AE01

ATC

ibuprofen; systemic, rectal

1.2

8.4

8254

76320

K02.1

ICD-10 Finland

Caries of dentine

0.9

8.3

4093

41885

C44.52

ICD-10 Finland

Spinocellular carcinoma of the skin on the torso

15.5

8.3

L04AX03

ATC

methotrexate; systemic

0.8

8.3

539

6610

Z08

ICD-10 Finland

Follow-up examination after treatment for malignant neoplasms

26.2

8.3

9844

FHL

Musculocutaneous tongue

85.8

8.2

HA1DT

NOMESCO Finland

Mammary gland biopsy with MRI guidance

85.8

8.2

9822

FHL

Myocutaneous graft

85.8

8.2

YN1BD

NOMESCO Finland

Extensive CT examination of extremities for dose design of radiotherapy

85.8

8.2

PJW20

NOMESCO Finland

Lymphovenous shunt

85.8

8.2

C43.51

ICD-10 Finland

Malignant melanoma of the trunk originating in lentigo maligna

85.8

8.2

N02AX02

ATC

tramadol; systemic, rectal

1.1

8.2

3466

30297

9680/3-C77.8

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of lymph nodes of multiple regions

+∞

8.2

8010/3-C50.4

ICD-O-3

Carcinoma, NOS, of upper-outer quadrant of breast

+∞

8.2

C18.51

ICD-10 Finland

Malignant tumor of flexura hiealis invasive carcinoma

+∞

8.2

8541/3-C50.9

ICD-O-3

Paget disease and infiltrating duct carcinoma of breast of breast, NOS

+∞

8.2

C49.19

ICD-10 Finland

Malignant tumor of connective tissue and soft tissue of upper extremity including shoulder other or unspecified tumor

+∞

8.2

C43.60

ICD-10 Finland

Malignant melanoma of the upper extremity including the shoulder without histology

+∞

8.2

PJD55

NOMESCO Finland

Block dissection of inguinal lymph nodes

+∞

8.2

YL1CD

NOMESCO Finland

Very extensive CT examination of pelvis for dose design of radiotherapy

+∞

8.2

C54.12

ICD-10 Finland

Adenosquamous carcinoma of the endometrium

+∞

8.2

1DB03, ,

NOMESCO Finland

+∞

8.2

17401

ICD-8 Finland

Malignant neoplasm of breast, Cutis

+∞

8.2

C91.0

ICD-10 Finland

Acute lymphoblastic leukaemia [ALL]

+∞

8.2

C80.0

ICD-10 Finland

Malignant neoplasm, primary site unknown, so stated

+∞

8.2

8501/2-C50.9

ICD-O-3

Comedocarcinoma, noninfiltrating of breast, NOS

+∞

8.2

C77.9

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph node, unspecified

+∞

8.2

C57.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of female genital organs

+∞

8.2

18301

ICD-8 Finland

Malignant neoplasm of ovary, Fallopian tube and broad ligament, Ovary

+∞

8.2

C43.73

ICD-10 Finland

Malignant melanoma of the lower extremity including the hip nodular

+∞

8.2

C18.60

ICD-10 Finland

Malignant tumor of the descending colon without histology

+∞

8.2

8140/3-C18.4

ICD-O-3

Adenocarcinoma, NOS, of transverse colon

+∞

8.2

8522/3-C50.2

ICD-O-3

Infiltrating duct and lobular carcinoma of upper-inner quadrant of breast

+∞

8.2

C43.6

ICD-10 Finland

Malignant neoplasm: Malignant melanoma of upper limb, including shoulder

+∞

8.2

8211/3-C50.5

ICD-O-3

Tubular adenocarcinoma of lower-outer quadrant of breast

+∞

8.2

8503/3-C50.9

ICD-O-3

Intraductal papillary adenocarcinoma with invasion of breast, NOS

+∞

8.2

C66

ICD-10 Finland

Malignant neoplasm of ureter

+∞

8.2

C18.22

ICD-10 Finland

Malignant tumor of the colon ascending carcinoma of the adenoma

+∞

8.2

C80.9

ICD-10 Finland

Malignant neoplasm, primary site unspecified

+∞

8.2

159

Kela drug reimbursment

Pazopanib

+∞

8.2

JAP00

NOMESCO Finland

Freeing of adhesions in the peritoneal cavity

2.2

8.2

300

EBA00

NOMESCO Finland

Extraction of tooth

0.9

8.2

2096

22414

6101A

ICD-9 Finland

Benign mammary dysplasias, Diffuse cystic mastopathy

2.4

8.1

216

A02BC05

ATC

esomeprazole; systemic

1.1

8.1

3700

32497

ZXE01

NOMESCO Finland

Procedure duration 0 to 9 minutes

1.9

8.1

456

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

0.9

8.1

3345

34618

G56.0

ICD-10 Finland

Carpal tunnel syndrome

0.8

8.1

905

10406

JFB44

NOMESCO Finland

Laparoscopic left hemicolectomy

4.8

8.0

HAD35

NOMESCO Finland

Reduction mammoplasty with transplantation of areola

4.0

8.0

R19.0

ICD-10 Finland

Intra-abdominal and pelvic swelling, mass and lump

1.6

8.0

182

1099

QXA25

NOMESCO Finland

Destruction of lesion of skin, site unspecified

1.8

8.0

119

643

XX9AN

NOMESCO Finland

Complementary isotope examination or additional picture

13.8

8.0

GD2AT

NOMESCO Finland

Cytology of the lungs with ultrasound guidance

13.8

8.0

ZX100

NOMESCO Finland

Oral

2.1

7.9

310

M75.1

ICD-10 Finland

Rotator cuff syndrome

0.9

7.9

1666

18096

I42.7

ICD-10 Finland

Cardiomyopathy due to drugs and other external agents

31.8

7.9

WE198

NOMESCO Finland

Palliative cystotatic therapy

31.8

7.9

C03CA01

ATC

furosemide; systemic

1.2

7.9

2383

20353

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.3

7.8

594

4443

PJD99

NOMESCO Finland

Excision of other lymph nodes

21.0

7.8

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.1

7.8

2654

22850

N60.2

ICD-10 Finland

Fibroadenosis of breast

2.2

7.8

275

GDB11

NOMESCO Finland

Thoracoscopic wedge resection of lung

3.7

7.8

EP1CG

NOMESCO Finland

Extensive MRI examination of soft tissue of neck with high intesity magnet

2.3

7.7

245

21899

ICD-8 Finland

Uterine fibroma

1.3

7.7

482

3509

P20

ICPC

Memory disturbance

0.8

7.7

828

9571

JCF12

NOMESCO Finland

Endoscopic insertion of prosthetic tube into oesphagus

6.9

7.6

R4190

NOMESCO Finland

Nutritional therapy

1.6

7.6

154

904

SPAT1193

SPAT

Pap smear

0.8

7.6

466

5756

N81.1

ICD-10 Finland

Cystocele

0.8

7.6

573

6889

JGB00

NOMESCO Finland

Partial proctectomy and colorectal or coloanal anastomosis

4.1

7.6

WPB10

NOMESCO Finland

Making a convalescent care decision

6.2

7.6

HAA00

NOMESCO Finland

Incision of mammary gland

4.5

7.5

WE100

NOMESCO Finland

Profylactic cytostatic therapy

42.9

7.5

JDD00

NOMESCO Finland

Total gastrectomy and Roux-en-Y oesophagojejunostomy

42.9

7.5

SPAT1310

SPAT

Counselling related to known health issue

0.9

7.5

2141

22748

R59.9

ICD-10 Finland

Enlarged lymph nodes, unspecified

2.4

7.5

195

S21

ICPC

Skin texture symptom/complaint

1.2

7.5

1033

8264

G03DA02

ATC

medroxyprogesterone; systemic

1.2

7.4

1079

8673

ZZR30

NOMESCO Finland

Flap of muscle

3.6

7.4

L91.0

ICD-10 Finland

Hypertrophic scar

2.0

7.4

357

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

2.0

7.4

390

TQX05

NOMESCO Finland

Skin puncture, unspecified location

3.9

7.4

L03.3

ICD-10 Finland

Cellulitis of trunk

2.3

7.4

214

NK6SN

NOMESCO Finland

Bone SPECT

17.5

7.4

Z25.8

ICD-10 Finland

Need for immunization against other specified single viral diseases

0.8

7.4

532

6437

J01FF01

ATC

clindamycin; systemic

1.2

7.3

2082

17695

21799

ICD-8 Finland

Benign neoplasm of breast

1.8

7.3

507

J05AB01

ATC

aciclovir; systemic

1.2

7.3

1861

15691

JCC12

NOMESCO Finland

Thoracoscopic or laparoscopic partial oesophagectomy

76.3

7.3

WW302

NOMESCO Finland

Allogenic transfer of stem cells from relative

76.3

7.3

9861/3-C42.1

ICD-O-3

Acute myeloid leukemia, NOS, of bone marrow

76.3

7.3

8743/3-C44.9

ICD-O-3

Low cumulative sun damage melanoma of skin, NOS

76.3

7.3

JAH01

NOMESCO Finland

Laparoscopy

1.4

7.2

291

1977

PD1AD

NOMESCO Finland

CT of abdominal aorta and branches

2.7

7.2

136

A02BA02

ATC

ranitidine; systemic

1.2

7.2

1626

13574

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

1.4

7.2

287

1949

L03

ICPC

Low back symptom/complaint

0.9

7.2

1968

20975

8503/3-C50.4

ICD-O-3

Intraductal papillary adenocarcinoma with invasion of upper-outer quadrant of breast

+∞

7.2

C18.50

ICD-10 Finland

Malignant tumor in flexural lienalis without histology

+∞

7.2

2008X

ICD-9 Finland

Lymphosarcoma and reticulosarcoma, Other named variants

+∞

7.2

BA1NN

NOMESCO Finland

I-131 dose capsel measurement

+∞

7.2

C84.0

ICD-10 Finland

Mycosis fungoides

+∞

7.2

8070/3-C34.9

ICD-O-3

Squamous cell carcinoma, NOS, of lung, NOS

+∞

7.2

3009

Kela drug reimbursment

Niraparib

+∞

7.2

C80

ICD-10 Finland

Malignant neoplasm, without specification of site

+∞

7.2

L01BC59

ATC

trifluridine, combinations; systemic

+∞

7.2

176

Kela drug reimbursment

Regorafenib

+∞

7.2

8140/3-C53.9

ICD-O-3

Adenocarcinoma, NOS, of cervix uteri

+∞

7.2

C16.23

ICD-10 Finland

Malignant tumor of the corpus ventriculi diffuse carcinoma

+∞

7.2

L01EF02

ATC

ribociclib; oral

+∞

7.2

C34.0

ICD-10 Finland

Malignant neoplasm: Main bronchus

+∞

7.2

L01XE04

ATC

[U] sunitinib

+∞

7.2

1AA09, ,

NOMESCO Finland

+∞

7.2

C83.34

ICD-10 Finland

Anaplastic large cell lymphoma

+∞

7.2

197

Kela drug reimbursment

Sunitinib

+∞

7.2

C34.80

ICD-10 Finland

Malignant overall tumor of bronchus and lung without histology

+∞

7.2

1506

Kela drug reimbursment

The combination of trifluridine and tipiracil

+∞

7.2

8520/2-C50.4

ICD-O-3

Lobular carcinoma in situ, NOS, of upper-outer quadrant of breast

+∞

7.2

WB223

NOMESCO Finland

Demanding adjuvant hormone therapy of malignancy

+∞

7.2

3018

Kela drug reimbursment

The combination of trifluridine and tipiracil

+∞

7.2

8480/3-C18.1

ICD-O-3

Mucinous adenocarcinoma of appendix

+∞

7.2

C95.0

ICD-10 Finland

Acute leukaemia of unspecified cell type

+∞

7.2

8201/3-C50.9

ICD-O-3

Cribriform carcinoma, NOS, of breast, NOS

+∞

7.2

C69.32

ICD-10 Finland

Malignant tumor of the chorioidea melanoma

+∞

7.2

C07.70

ICD-10 Finland

Malignant tumor of the superficial part of the parotid gland

+∞

7.2

C21.0

ICD-10 Finland

Malignant neoplasm: Anus, unspecified

+∞

7.2

8240/3-C17.9

ICD-O-3

Neuroendocrine tumor, NOS, of small intestine, NOS

+∞

7.2

WC402

NOMESCO Finland

Demanding antibody therapy of local recurrence of tumour

+∞

7.2

369

Kela drug reimbursment

Regorafenib

+∞

7.2

8507/3-C50.4

ICD-O-3

Invasive micropapillary carcinoma of breast of upper-outer quadrant of breast

+∞

7.2

C49.29

ICD-10 Finland

Malignant tumor of connective tissue and soft tissue of lower extremity including hip other or unspecified tumor

+∞

7.2

9691/3-C42.1

ICD-O-3

Follicular lymphoma, grade 2 of bone marrow

+∞

7.2

1XC07, ,

NOMESCO Finland

+∞

7.2

9863/3-C42.1

ICD-O-3

Chronic myeloid leukemia, NOS, of bone marrow

+∞

7.2

8200/3-C50.9

ICD-O-3

Adenoid cystic carcinoma of breast, NOS

+∞

7.2

XX9XW, ,

NOMESCO Finland

2.7

7.2

126

SFA30

NOMESCO Finland

Three-surface restoration

0.9

7.1

2984

30927

ZXC50

NOMESCO Finland

Cryotherapy

1.6

7.0

150

893

OAB42, ,

SPAT

0.8

7.0

453

5560

A03CA05

ATC

glycopyrronium bromide and psycholeptics; systemic

1.8

7.0

513

SDA01

NOMESCO Finland

Periodontal treatment, very brief

0.9

7.0

1735

18629

XX9CN, ,

NOMESCO Finland

28.6

7.0

EN1AD

NOMESCO Finland

CT examination of mouth and soft tissues of neck

2.2

7.0

226

A40.8

ICD-10 Finland

Other streptococcal sepsis

2.5

7.0

150

XLD00

NOMESCO Finland

Sytologyspecimen from mouth of uterus

1.2

6.9

984

7892

QBE15

NOMESCO Finland

Excision of other superficial lesion of skin of trunk

3.3

6.9

SPAT1028

SPAT

Ultrasound examination of paranasal sinuses

0.7

6.9

255

3404

C10AA07

ATC

rosuvastatin; oral

0.9

6.9

2328

24477

A10AE04

ATC

insulin glargine; parenteral

0.7

6.9

335

4276

C43

ICD-10 Finland

Malignant melanoma of skin

11.4

6.9

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.5

6.8

195

1242

G03FA01

ATC

norethisterone and estrogen; systemic

0.9

6.8

1361

14860

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

2.1

6.8

291

A06AD11

ATC

lactulose; oral

1.2

6.8

1065

8622

ZX122

NOMESCO Finland

Intra-arterial

3.8

6.8

XX2XW

NOMESCO Finland

Other teleradiological consultation

2.9

6.8

103

G47.3

ICD-10 Finland

Sleep apnoea

0.8

6.8

1074

11957

Z93.3

ICD-10 Finland

Colostomy status

3.2

6.8

WZC30, ,

SPAT

0.7

6.7

243

3256

M05BA04

ATC

alendronic acid; oral

1.2

6.7

931

7448

D48.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Neoplasm of uncertain or unknown behaviour, unspecified

1.7

6.7

104

569

L88

ICPC

Rheumatoid/seropositive arthritis

0.7

6.7

202

2797

XX1XW

NOMESCO Finland

Extensive written report from radiologist

1.7

6.7

112

627

N06AX11

ATC

mirtazapine; oral

1.1

6.7

2955

25824

WPA16

NOMESCO Finland

Extensive demanding palliative symptom assessment and treatment

13.1

6.7

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.3

6.6

544

4111

ZXC20

NOMESCO Finland

Use of chemical agents

1.8

6.6

502

KCC30

NOMESCO Finland

Cystectomy with excision of female internal genital organs

38.1

6.6

F43.29

ICD-10 Finland

Adaptation disorder UNS

1.7

6.6

123

709

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

1.6

6.6

135

797

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

1.4

6.6

277

1900

E11

ICD-10 Finland

Type 2 diabetes mellitus

0.8

6.6

783

8951

JN4KR

NOMESCO Finland

Whole body very extensive metabolic PET with CT

3.9

6.5

QX4YT

NOMESCO Finland

Puncture of superficial collection under ultrasound guidance

3.3

6.5

SAD01

NOMESCO Finland

Assessment of need for oral health care, standard

0.8

6.5

692

8007

D37.6

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts

2.1

6.5

283

L58.9

ICD-10 Finland

Radiodermatitis, unspecified

21.4

6.5

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.2

6.5

787

6215

G03CA04

ATC

estriol; systemic, vaginal

1.2

6.5

873

6967

EB1CI

NOMESCO Finland

Cone beam imaging of teeth and jaws (3-4 quarters)

2.3

6.5

185

A07AA09

ATC

vancomycin; oral

1.8

6.5

513

KMAK, ,

NOMESCO Finland

0.9

6.5

3671

37445

JMA10

NOMESCO Finland

Transabdominal total splenectomy

3.7

6.4

N05CF02

ATC

zolpidem; oral

1.2

6.4

1460

12194

J01CR50

ATC

combinations of penicillins; systemic

3.8

6.4

LFC00

NOMESCO Finland

Partial excision of vulva

3.5

6.4

601

Kela drug reimbursment

Severe malabsorption of nutrients, mainly fats

2.8

6.4

107

N03AX16

ATC

[U] pregabalin

1.1

6.4

1963

16759

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

1.4

6.3

320

2261

6119X

ICD-9 Finland

Other disorders of breast, Unspecified breast disorder

8.3

6.3

C18.10

ICD-10 Finland

Malignant tumor of the appendix without histology

66.6

6.3

C53.0

ICD-10 Finland

Malignant neoplasm: Endocervix

66.6

6.3

C53.11

ICD-10 Finland

Squamous cell carcinoma and exocervix

66.6

6.3

JN4ED

NOMESCO Finland

Body CT examination with specail preparation

66.6

6.3

C44.59

ICD-10 Finland

Malignant tumor of the skin on the trunk other or unspecified histology

66.6

6.3

I31.9

ICD-10 Finland

Disease of pericardium, unspecified

2.4

6.3

164

D22.9

ICD-10 Finland

Melanocytic naevi, unspecified

1.4

6.2

280

1943

M54.4

ICD-10 Finland

Lumbago with sciatica

0.8

6.2

1155

12692

FN2BA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty with stent (includes balloon pre-dilation)

0.6

6.2

143

2086

WX600

NOMESCO Finland

Single shot through catheter

2.0

6.2

328

JA1AE

NOMESCO Finland

Ultrasound examination of groin and abdominal wall

1.8

6.1

493

8240/3-C18.2

ICD-O-3

Neuroendocrine tumor, NOS, of ascending colon

+∞

6.1

YX9VG

NOMESCO Finland

Other MRI eamination with high intensity magnet for dose design of radiotherapy

+∞

6.1

8260/3-C64.9

ICD-O-3

Papillary adenocarcinoma, NOS, of kidney, NOS

+∞

6.1

8140/3-C25.0

ICD-O-3

Adenocarcinoma, NOS, of head of pancreas

+∞

6.1

C54.21

ICD-10 Finland

Leiomyosarcoma and myometrium

+∞

6.1

Z85.7

ICD-10 Finland

Personal history of other malignant neoplasms of lymphoid, haematopoietic and related tissues

+∞

6.1

8145/3-C16.9

ICD-O-3

Carcinoma, diffuse type of stomach, NOS

+∞

6.1

9691/3-C77.9

ICD-O-3

Follicular lymphoma, grade 2 of lymph node, NOS

+∞

6.1

8070/3-C02.1

ICD-O-3

Squamous cell carcinoma, NOS, of border of tongue

+∞

6.1

C43.69

ICD-10 Finland

Malignant melanoma of the upper extremity including shoulder other or unspecified histology

+∞

6.1

8091/3-C44.9

ICD-O-3

Superficial basal cell carcinoma of skin, NOS

+∞

6.1

8480/3-C50.3

ICD-O-3

Mucinous adenocarcinoma of lower-inner quadrant of breast

+∞

6.1

C67.0

ICD-10 Finland

Malignant neoplasm: Trigone of bladder

+∞

6.1

C34.20

ICD-10 Finland

Malignant tumor of the middle lobe, bronchus or lung without histology

+∞

6.1

C18.4

ICD-10 Finland

Malignant neoplasm: Transverse colon

+∞

6.1

C50.6

ICD-10 Finland

Malignant neoplasm: Axillary tail of breast

+∞

6.1

C16.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of stomach

+∞

6.1

C71.1

ICD-10 Finland

Malignant neoplasm: Frontal lobe

+∞

6.1

CKE60

NOMESCO Finland

Brachytherapy of choroid and retina

+∞

6.1

1BA04, ,

NOMESCO Finland

+∞

6.1

CKE65

NOMESCO Finland

Removal of brachytherapeutic plate from eye

+∞

6.1

C49.38

ICD-10 Finland

Malignant tumor of connective tissue and soft tissue of the chest Ewing's sarcoma

+∞

6.1

C16.2

ICD-10 Finland

Malignant neoplasm: Body of stomach

+∞

6.1

C18.9

ICD-10 Finland

Malignant neoplasm: Colon, unspecified

+∞

6.1

8041/3-C34.1

ICD-O-3

Small cell carcinoma, NOS, of upper lobe, lung

+∞

6.1

8507/3-C50.9

ICD-O-3

Invasive micropapillary carcinoma of breast of breast, NOS

+∞

6.1

C34.81

ICD-10 Finland

Malignant overall tumor of bronchial and pulmonary epidermoid carcinoma

+∞

6.1

Z08.2

ICD-10 Finland

Follow-up examination after chemotherapy for malignant neoplasm

+∞

6.1

C18.91

ICD-10 Finland

Malignant tumor of unspecified location in colon invasive carcinoma

+∞

6.1

8310/3-C56.9

ICD-O-3

Clear cell adenocarcinoma, NOS, of ovary

+∞

6.1

C71.13

ICD-10 Finland

Malignant tumor of frontal lobe grade IV glioma

+∞

6.1

L01XX52

ATC

venetoclax; oral

+∞

6.1

C71.99

ICD-10 Finland

Malignant tumor in unspecified localization in the brain other or unspecified histology

+∞

6.1

1510

Kela drug reimbursment

Niraparib

+∞

6.1

C79.0

ICD-10 Finland

Secondary malignant neoplasm of kidney and renal pelvis

+∞

6.1

158

Kela drug reimbursment

Everolimus

+∞

6.1

C49.49

ICD-10 Finland

Malignant tumor of connective tissue and soft tissue of the abdomen other or unspecified tumor

+∞

6.1

1512

Kela drug reimbursment

Ibrutinib

+∞

6.1

C76.1

ICD-10 Finland

Malignant neoplasm of other and ill-defined sites: Thorax

+∞

6.1

C71.30

ICD-10 Finland

Malignant tumor in parietal lobe without histology

+∞

6.1

8480/3-C50.2

ICD-O-3

Mucinous adenocarcinoma of upper-inner quadrant of breast

+∞

6.1

C49.3

ICD-10 Finland

Malignant neoplasm: Connective and soft tissue of thorax

+∞

6.1

9699/3-C50.9

ICD-O-3

Marginal zone B-cell lymphoma, NOS, of breast, NOS

+∞

6.1

8010/2-C50.9

ICD-O-3

Carcinoma in situ, NOS, of breast, NOS

+∞

6.1

8461/3-C48.2

ICD-O-3

High grade serous carcinoma of peritoneum, NOS

+∞

6.1

C84.49

ICD-10 Finland

Peripheral T-cell lymphoma, unspecified cell type

+∞

6.1

8480/3-C50.5

ICD-O-3

Mucinous adenocarcinoma of lower-outer quadrant of breast

+∞

6.1

390

Kela drug reimbursment

Ibrutinib

+∞

6.1

C51.9

ICD-10 Finland

Malignant neoplasm: Vulva, unspecified

+∞

6.1

185

Kela drug reimbursment

docetaxel

+∞

6.1

L01EF01

ATC

palbociclib; oral

+∞

6.1

C51.00

ICD-10 Finland

Malignant tumor of the labium majus without histology

+∞

6.1

8140/3-C18.5

ICD-O-3

Adenocarcinoma, NOS, of splenic flexure of colon

+∞

6.1

8470/3-C56.9

ICD-O-3

Mucinous cystadenocarcinoma, NOS, of ovary

+∞

6.1

C16.33

ICD-10 Finland

Malignant tumor of the antrum ventriculi diffuse carcinoma

+∞

6.1

8201/3-C50.4

ICD-O-3

Cribriform carcinoma, NOS, of upper-outer quadrant of breast

+∞

6.1

C78.1

ICD-10 Finland

Secondary malignant neoplasm of mediastinum

+∞

6.1

C88.0

ICD-10 Finland

Waldenström macroglobulinaemia

+∞

6.1

C16.3

ICD-10 Finland

Malignant neoplasm: Pyloric antrum

+∞

6.1

8480/3-C50.1

ICD-O-3

Mucinous adenocarcinoma of central portion of breast

+∞

6.1

C574, 8461, 3

ICD-O-3

+∞

6.1

M49.5*C79.5

ICD-10 Finland

Metastatic fracture of vertebra

+∞

6.1

C34.86

ICD-10 Finland

Malignant overall tumor of bronchial and pulmonary microcellular carcinoma

+∞

6.1

BA3AT

NOMESCO Finland

Cytology of thyroid with ultrasound quidance

1.7

6.1

102

571

T80.8

ICD-10 Finland

Other complications following infusion, transfusion and therapeutic injection

7.7

6.1

QC9S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in upper extremities, unspecified

7.7

6.1

C44.3

ICD-10 Finland

Malignant neoplasm: Skin of other and unspecified parts of face

17.2

6.1

PJD44

NOMESCO Finland

Excision of iliac lymph nodes

10.5

6.1

JN5KR

NOMESCO Finland

Very extensive PET-CT of upper body metabolism (eyebrows to thighs)

10.5

6.1

NF3AA

NOMESCO Finland

Femur X-ray examination

1.6

6.1

137

829

C54

ICD-10 Finland

Malignant neoplasm of corpus uteri

25.4

6.1

2383A

ICD-9 Finland

Neoplasm of uncertain behaviour of other and unspecified sites and tissues, Breast

8.8

6.1

SPAT1262

SPAT

Handing over of treatment supplies

0.8

6.0

871

9779

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

685

79.58

307.65

3.0

1.1

31.19

16.98

u/ml

2.74

675

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

5347

32314

2.25

307.65

2.5

2.2

—

(3002256) Pathology report gross observation

2406

6327

4.46

307.65

1.3

1.1

—

(3044640) Blood type and Crossmatch panel - Blood

3972

21146

2.32

307.65

2.3

2.0

—

(4035726) Immunohistochemistry procedure

2566

2104

15.33

307.65

1.5

1.2

—

(40768795) Lymph node Pathology biopsy report

427

112

37.90

307.65

1.1

—

(40768804) Tissue Pathology biopsy report

5057

28881

2.37

307.65

2.4

1.7

—

(40768793) Breast Pathology biopsy report

1915

679

33.07

307.65

1.4

1.2

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

6095

36971

2.49

307.65

7.6

3.4

9.97

10.41

umol/l

2.28

5848

34249

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

226

32.37

307.65

1.2

1.1

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1778

4144

4.76

307.65

3.4

1.5

14.51

2.63

ug/l

4.73

1334

3053

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

1231

153

87.38

307.65

3.2

1.1

32.32

14.42

u/ml

5.96

1191

136

(3015377) Calcium [Moles/volume] in Serum or Plasma

4565

26567

2.18

300.23

4.6

2.1

2.38

2.37

mmol/l

15.22

4105

22236

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

8119

60082

2.60

289.75

9.3

5.3

79.92

75.57

u/l

11.68

7769

55290

(3013650) Neutrophils [#/volume] in Blood by Automated count

6287

41800

2.19

289.45

10.5

6.4

3.70

4.07

e9/l

36.79

5546

35709

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

612

1264

4.85

258.91

1.2

1.3

—

(40758558) Short blood count panel - Blood

3281

17771

2.13

248.00

7.6

4.8

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

2864

15975

2.00

190.12

2.2

2.0

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1246

5396

2.37

154.79

1.8

2.0

0.23

0.21

g/l

8.30

1193

4891

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

1035

4466

2.35

128.42

3.3

1.4

91.22

24.42

u/ml

1.62

1011

4243

(3023368) Bacteria identified in Blood by Culture

2650

16702

1.70

106.76

4.2

3.6

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

4834

35942

1.55

95.02

5.2

4.6

1.22

mmol/l

0.87

4390

31854

(3003694) ABO and Rh group [Type] in Blood

2647

17110

1.65

94.73

1.4

1.3

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

4420

32366

1.54

92.04

4.2

3.5

35.51

35.98

g/l

6.79

4075

29353

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

5266

40068

1.54

91.92

6.0

5.0

1.23

mmol/l

0.30

4380

33790

(3033658) Prothrombin time (PT) actual/Normal

2620

17573

1.57

77.54

3.5

3.2

94.66

94.28

0.33

2569

16990

(3042936) Bacteria identified in Isolate by Culture

1512

8877

1.73

75.59

1.9

—

(3018418) pH of Serum or Plasma

3246

23940

1.43

56.43

3.8

3.0

7.40

1.22

636

3976

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1634

10471

1.58

56.43

3.0

2.2

0.82

mmol/l

0.02

1522

9483

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

8.27

55.84

5.8

1.5

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1043

6238

1.66

47.11

4.3

2.7

251.50

239.57

u/l

1.83

969

5740

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

369

1583

2.27

45.41

2.9

1.9

2497.40

17.17

u/ml

0.83

321

1259

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1146

7163

1.59

43.09

3.3

3.1

—

(3022217) INR in Platelet poor plasma by Coagulation assay

4239

33988

1.33

39.57

13.2

14.0

1.27

1.22

inr

0.17

1237

9573

(4281824) Cell count and differential, peritoneal fluid

168

528

3.07

38.75

1.1

—

(40768806) Pleura Pathology biopsy report

122

322

3.64

37.14

1.4

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1590

11116

1.43

34.25

1.9

1.7

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

5275

44159

1.29

33.59

4.2

3.8

6.45

6.63

mmol/l

10.18

4988

40869

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

2071

15357

1.36

31.06

3.1

2.3

2.47

2.46

mmol/l

8.21

1821

13109

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

8256

82407

0.72

28.95

5.0

5.2

2.87

2.85

mmol/l

0.81

7389

75630

(3003434) Protein [Mass/volume] in Pleural fluid

143

498

2.76

27.53

1.3

1.4

32.06

28.90

g/l

2.11

129

422

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

8073

80755

0.74

27.31

4.4

4.6

4.93

4.88

mmol/l

4.20

7253

74370

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

7665

77233

0.76

27.20

3.9

4.1

1.24

1.26

mmol/l

2.78

6768

70034

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

8391

75653

1.37

26.65

15.8

10.9

79.41

77.74

ml/min/173m2

12.97

7294

60375

(3012441) Differential panel - Pleural fluid

115

367

3.01

25.97

1.4

—

(3002030) Lymphocytes/100 leukocytes in Blood

4377

36482

1.26

25.95

5.5

5.8

27.15

29.03

22.90

4066

33752

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

8011

80109

0.75

25.62

4.4

4.6

1.64

1.60

mmol/l

8.34

7161

73396

(3019069) Monocytes/100 leukocytes in Blood

4280

35621

1.25

25.56

5.7

6.0

8.70

8.33

8.57

3964

32870

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

175

699

2.41

25.49

1.3

0.37

0.40

nmol/l

0.18

116

521

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2964

23662

1.28

25.06

3.5

2.6

33.72

31.43

u/l

0.39

2811

22201

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

275

1329

2.00

24.95

1.3

1.2

—

(3022096) Basophils/100 leukocytes in Blood

4128

34337

1.25

24.36

5.5

5.8

0.68

0.71

3.34

3809

31500

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

263

1269

2.00

23.98

1.6

1.3

—

(3006504) Eosinophils/100 leukocytes in Blood

4244

35451

1.25

23.98

5.4

5.7

2.67

2.92

10.44

3926

32633

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

7569

76115

0.77

23.64

5.4

5.8

39.11

39.63

mmol/mol

5.80

6787

69871

(3018010) Neutrophils/100 leukocytes in Blood

4305

36062

1.24

23.55

5.4

5.7

57.50

56.54

5.17

3990

33315

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1094

7621

1.41

23.38

1.8

1.7

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1093

7613

1.41

23.37

1.7

—

(3019225) pH of Specimen

1178

8352

1.39

22.67

4.2

3.6

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

248

1202

1.99

22.36

1.6

1.4

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

117

414

2.71

21.94

1.4

42132.81

48273.09

e6/l

0.09

233

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

315

1671

1.82

21.60

1.7

1.6

—

(3044889) 12 lead EKG panel

6420

56406

1.24

21.58

3.8

3.7

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

6.20

21.52

1.1

1.3

638.33

28.92

ug/l

0.57

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

196

884

2.13

21.47

1.2

1.1

56.59

56.97

u/l

0.05

175

775

(3023199) Leukocytes [#/volume] in Pleural fluid

125

468

2.56

20.97

1.4

2796.32

2953.82

e6/l

0.04

336

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

633

4052

1.52

20.88

1.7

1.6

—

(3021589) Normoblasts [#/volume] in Blood

4045

33971

1.23

20.62

10.0

8.2

0.00

e9/l

1.00

3219

27712

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

207

969

2.06

20.58

1.3

1.4

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

786

5294

1.45

20.11

1.6

—

(36304419) Bacteria [Presence] in Urine

2488

19872

1.26

20.00

2.9

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

194

897

2.08

19.95

1.6

1.4

—

(40760892) CBC W Ordered Manual Differential panel - Blood

4210

35624

1.22

19.56

5.7

5.8

—

(3020682) Albumin/Creatinine [Ratio] in Urine

2218

25151

0.79

19.35

3.4

3.6

6.10

6.98

mg/mmol

0.53

1150

14174

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

286

1526

1.81

19.28

2.0

2.4

3.61

3.57

g/l

0.19

276

1426

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

271

1424

1.84

19.20

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

271

1424

1.84

19.20

1.3

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

357

2041

1.69

18.89

1.5

1.4

216.22

69.87

pmol/l

4.37

348

1995

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

908

6352

1.40

18.77

3.5

2.8

1.24

mmol/l

0.34

805

5289

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

184

854

2.07

18.76

1.7

1.3

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

184

854

2.07

18.76

1.7

1.3

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

783

5354

1.43

18.43

5.7

5.6

1.26

1.34

mmol/l

1.83

763

5204

(3013512) EKG study

2920

23937

1.23

18.16

3.8

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

315

1761

1.73

18.11

1.6

1.9

94.36

95.61

0.44

305

1647

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1363

10210

1.31

18.00

1.9

1.8

29.39

29.46

0.14

1319

9847

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

186

881

2.03

17.96

3.1

1.9

480.78

21.43

u/ml

1.10

166

792

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1478

11200

1.30

17.93

2.6

4.04

4.96

e6/l

1.59

749

5772

(3030467) Casts [#/volume] in Urine by Automated count

2515

20318

1.24

17.89

2.9

0.42

e6/l

0.01

1838

15178

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

113

439

2.47

17.63

1.1

1.2

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

104

389

2.56

17.56

1.4

1.1

6.42

2.49

ug/l

0.38

305

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

241

3.02

17.50

1.2

9.93

10.67

u/l

0.18

205

(3007853) Bacteria identified in Skin by Aerobe culture

1137

8346

1.34

17.27

1.7

1.8

—

(3012516) Albumin [Mass/volume] in Urine

2118

23874

0.80

17.02

2.9

3.1

496.41

404.30

mg/l

0.31

1105

13379

(3009508) Creatinine [Moles/volume] in Urine

2207

24749

0.81

16.87

2.9

3.0

6.21

6.28

mmol/l

0.44

1774

20685

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

8639

79211

1.31

16.60

16.1

12.0

21.96

20.09

mg/l

6.09

6987

60893

(3045788) Cell count panel - Pleural fluid

367

2.56

16.54

1.5

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

297

1678

1.71

16.47

1.9

2.2

197.91

180.06

2.71

285

1557

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

298

1696

1.69

16.09

2.4

3.1

0.36

0.38

u/ml

0.63

166

1024

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

481

3075

1.51

15.97

7.4

7.5

24.62

24.65

mmol/l

0.08

464

2941

(3035637) Corticotropin [Mass/volume] in Plasma

146

662

2.12

15.90

1.5

1.4

—

(3002582) Erythrocytes [#/volume] in Urine

2655

21866

1.21

15.19

3.0

109.54

75.84

e6/l

0.40

1937

16258

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

124

542

2.19

14.84

1.1

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

119

513

2.22

14.74

1.3

1.2

20.17

20.96

u/l

0.05

100

434

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

127

565

2.16

14.56

1.3

1.4

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

120

524

2.20

14.41

1.3

1.2

65.55

79.00

u/l

1.34

108

459

(3000991) Gas panel - Venous blood

709

4981

1.38

14.22

7.0

6.6

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

173

3.15

14.20

2.4

2.8

—

(3003396) Base excess in Arterial blood by calculation

962

7084

1.32

14.19

6.0

1.08

1.47

mmol/l

2.54

810

5645

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

274

2.65

13.91

1.5

11.58

13.23

u/l

1.63

262

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

313

1875

1.61

13.89

2.2

2.9

—

(3019198) Lymphocytes [#/volume] in Blood

4529

39364

1.18

13.71

5.3

5.6

1.73

1.90

e9/l

12.45

3909

34618

(3013115) Eosinophils [#/volume] in Blood

4569

39796

1.17

13.33

5.4

5.7

0.17

0.19

e9/l

23.40

3886

34693

(3051651) Icteric interference index of Serum or Plasma

322

2.47

13.11

2.4

3.8

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

174

900

1.86

13.11

3.7

4.7

667.68

1015.63

iu/ml

0.30

114

(3045142) Bone marrow Pathology biopsy report

104

447

2.23

13.03

1.3

1.1

—

(3001604) Monocytes [#/volume] in Blood

4408

38332

1.17

12.99

5.2

5.5

0.55

0.56

e9/l

0.98

3701

32956

(3019550) Sodium [Moles/volume] in Serum or Plasma

8997

83341

1.31

12.94

17.4

14.0

139.65

139.83

mmol/l

8.34

8769

80876

(3006315) Basophils [#/volume] in Blood

4418

38433

1.17

12.94

5.2

5.5

0.04

e9/l

8.91

3702

32984

(3027801) Oxygen [Partial pressure] in Arterial blood

954

7112

1.31

12.85

6.1

6.0

13.45

11.89

kpa

10.92

917

6728

(3014007) Fractional oxyhemoglobin in Arterial blood

539

3678

1.42

12.82

7.5

94.57

93.38

5.64

539

3666

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

343

2.40

12.80

1.3

1.5

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

954

7116

1.31

12.79

6.1

6.0

5.13

5.08

kpa

0.96

918

6736

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

4351

37844

1.17

12.67

2.2

2.3

81.59

2537.97

nmol/l

0.50

3815

33366

(3004809) Band form neutrophils/100 leukocytes in Blood

162

830

1.87

12.59

3.0

2.8

1.68

1.05

1.41

145

721

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

536

3674

1.41

12.44

7.5

0.74

0.70

1.72

536

3652

(21494814) CD8 cells/100 lymphocytes in Specimen

143

3.21

12.38

1.9

—

(3018095) Leukocytes [#/volume] in Urine

3163

26851

1.18

12.36

3.5

112.11

123.89

e6/l

0.34

2113

17960

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

351

2220

1.52

12.32

1.9

1.8

1.21

2.32

ug/l

2.83

312

1885

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

190

1034

1.76

12.14

1.3

36.13

36.51

u/l

0.05

177

784

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

537

3698

1.40

12.13

7.5

7.4

1.28

1.41

3.54

537

3672

(3036489) Thrombin time

373

2401

1.50

12.05

1.5

1.8

21.33

21.37

0.04

337

2043

(3024891) Influenza virus A+B Ag [Presence] in Specimen

278

1678

1.59

12.01

1.1

1.2

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

8151

80174

0.82

11.97

4.7

4.8

5.82

5.87

mmol/l

4.36

7279

72828

(3019150) Specific gravity of Urine by Refractometry

1648

18486

0.82

11.85

4.7

4.6

1.01

kg/l

0.26

258

2895

(3023103) Potassium [Moles/volume] in Serum or Plasma

9005

83558

1.29

11.70

17.6

14.1

3.93

3.94

mmol/l

6.44

8764

80910

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

110

3.47

11.70

1.7

1.9

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1575

12606

1.23

11.57

2.5

1.20

1.37

e6/l

1.08

847

7132

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

368

2.26

11.38

5.6

1.2

61.94

277.03

u/ml

2.34

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

362

2.25

10.96

3.8

1.2

180.10

72.81

nmol/l

1.96

355

(3014576) Chloride [Moles/volume] in Serum or Plasma

1028

7896

1.27

10.91

6.2

5.5

104.06

103.91

mmol/l

0.39

1028

7891

(3002385) Erythrocyte distribution width [Ratio]

7493

68402

1.18

10.61

19.6

14.0

15.17

15.18

0.03

7390

66976

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1038

8017

1.26

10.50

2.2

2.1

6.85

6.10

umol/l

0.73

878

6683

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

219

2.58

10.30

2.3

1.3

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

219

2.58

10.30

2.3

1.3

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

+∞

10.22

1.0

0.0

—

(40765096) Chromosome analysis panel by Banding

4.05

10.19

1.2

1.1

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

296

2.33

10.11

2.1

1.2

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

883

6723

1.28

10.06

2.1

2.2

36.48

36.02

u/l

0.05

748

5637

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

128

659

1.86

9.90

2.1

2.2

488.33

1263.87

u/ml

—

(1175426) CD3 cells/100 lymphocytes in Blood

299

2.30

9.89

1.7

1.9

71.37

73.89

0.67

284

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

299

2.30

9.89

2.1

1.2

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

226

2.50

9.68

2.3

1.3

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

112

559

1.92

9.54

1.4

1.3

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

112

559

1.92

9.54

1.4

1.3

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

759

5719

1.29

9.40

6.8

6.6

117.51

120.01

g/l

3.41

748

5540

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

390

2673

1.41

9.13

1.9

1.8

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

8004

78518

0.85

9.06

5.5

5.4

1.90

2.08

mu/l

2.02

7218

71985

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

419

2913

1.39

9.02

2.2

1.8

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

135

731

1.77

8.91

1.7

1.2

—

(3014891) Appearance of Pleural fluid

3.73

8.84

1.3

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

104

522

1.91

8.75

1.8

1.5

5.10

6.71

u/l

0.73

417

(3026782) Osmolality of Urine

1754

14525

1.18

8.74

2.7

2.8

491.39

497.31

mosm/kgh2o

0.58

1462

12207

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1456

16107

0.84

8.69

1.2

1.3

10.36

13.84

u/ml

1.25

517

6136

(3016502) Oxygen saturation in Arterial blood

811

6235

1.26

8.52

6.4

6.3

96.08

95.39

2.63

792

5971

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

130

706

1.76

8.51

1.3

1.4

—

(3052851) Hemolysis interference index of Serum or Plasma

329

2218

1.43

8.48

2.9

3.0

—

(3031040) Bacteria [#/volume] in Urine by Automated count

6029

54535

1.14

8.34

5.0

4.8

5368.40

2461.47

e6/l

1.20

662

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

274

2.23

8.26

1.6

2.0

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

3.29

8.17

1.1

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

103

528

1.87

8.16

1.9

1.3

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1077

8587

1.22

8.08

4.5

4.2

1.04

mmol/l

0.39

983

7776

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

160

934

1.64

8.07

1.5

1.6

—

(3011412) CD3 cells [#/volume] in Blood

410

1.98

8.06

2.5

2.1

1.05

1.45

e9/l

0.96

366

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

412

1.97

7.96

1.1

76.98

75.13

u/l

0.11

356

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

413

1.97

7.91

1.1

17.52

18.34

u/l

0.09

357

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1164

9382

1.21

7.80

2.2

2.4

20.80

21.63

1.29

1004

7808

(3021879) Hepatitis B virus core Ab [Presence] in Serum

527

3895

1.30

7.60

1.2

1.3

—

(3035880) pH of Pleural fluid

206

2.36

7.55

1.2

1.1

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

107

2.94

7.51

2.9

1.2

64.67

74.70

ng/l

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

5.85

7.21

1.6

1.0

1.29

1.47

ug/l

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

112

617

1.74

7.06

1.2

1.1

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

494

1.82

6.95

1.9

1.2

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

494

1.82

6.95

1.9

1.2

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

494

1.82

6.95

1.9

1.2

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

107

585

1.75

6.93

1.8

1.3

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

2122

18117

1.15

6.93

1.4

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

6955

68563

0.89

6.76

4.6

4.5

14.91

14.86

pmol/l

1.17

6242

62350

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1558

16806

0.86

6.64

1.3

35.55

37.72

iu/ml

0.22

492

5595

(40768443) Skin Pathology biopsy report

466

3459

1.30

6.55

1.3

1.2

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

161

993

1.55

6.54

1.3

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

126

740

1.63

6.30

1.3

—

(3022475) Manganese [Moles/volume] in Blood

4.05

6.26

1.1

1.2

—

(3020779) Urea [Moles/volume] in Serum or Plasma

631

4890

1.24

6.23

6.0

9.34

9.78

mmol/l

0.87

600

4611

(3027945) Reticulocytes/100 erythrocytes in Blood

903

7262

1.20

6.19

2.2

1.79

1.82

0.43

795

6234

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

432

1.81

6.07

1.3

1.4

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

9079

85029

1.21

5.98

12.9

9.2

24.08

23.43

u/l

1.71

8782

81203

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

168

2.33

5.96

1.1

1.8

703.40

66592.67

u/ml

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

145

2.44

5.93

1.8

2.3

964.05

1226.39

e6/l

0.14

102

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

106

1633

0.61

5.90

2.3

2.2

132.69

63.67

ug/min

0.82

874

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

528

1.72

5.88

2.4

2.6

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

2.78

5.83

1.3

1.7

36.82

21.86

g/l

5.09

(21494755) Public health laboratory ask at order entry panel

466

5563

0.79

5.83

1.4

1.3

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

889

7180

1.20

5.83

2.4

1.8

390.87

370.42

nmol/l

2.29

820

6481

(3009214) Lutropin [Units/volume] in Serum or Plasma

129

779

1.58

5.80

1.2

19.91

18.60

u/l

0.36

113

613

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

3.65

5.78

1.3

19.50

11.87

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1221

10144

1.17

5.72

2.1

2.3

2.35

2.41

g/l

3.10

1115

9204

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

416

3106

1.29

5.64

7.8

7.9

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

291

2070

1.35

5.58

1.2

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

128

781

1.57

5.52

1.3

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

783

6286

1.20

5.49

1.4

1.5

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

103

598

1.65

5.45

3.1

2.9

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

163

2.28

5.45

1.9

2.5

43.96

48.74

1.11

103

(3044007) Cell count panel - Peritoneal fluid

117

2.53

5.40

1.9

2.1

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

3.04

5.37

2.1

—

(4034850) Laboratory test

231

2992

0.73

5.30

12.2

9.1

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

119

2.49

5.22

1.4

1.3

59.44

58.03

0.07

(3020630) Protein [Mass/volume] in Serum or Plasma

720

5769

1.20

5.16

2.6

1.5

65.48

66.83

g/l

4.32

644

5056

(40768441) Liver Pathology biopsy report

364

1.81

5.15

1.2

1.4

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

2663

23424

1.11

5.12

2.8

1316.97

1233.86

ng/l

0.48

2261

19757

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

+∞

5.11

1.0

0.0

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

324

1.86

5.10

1.2

1.3

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

840

6836

1.19

5.07

3.0

3.1

84.44

81.37

ng/l

0.46

718

5698

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

137

867

1.51

5.05

1.4

1.3

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

2048

17763

1.12

5.05

1.6

1.7

1.22

1.05

mg/l

1.59

1584

13510

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

3.76

5.03

1.9

3.7

0.58

1.81

mg/l

—

(40761536) Microorganisms panel - Urine sediment

785

6355

1.19

5.03

4.3

4.2

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

755

6092

1.20

5.02

3.3

2.2

64.63

64.35

ml/min/173m2

0.08

314

2378

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

2819

24917

1.11

4.91

2.5

2.2

60.27

58.85

u/l

0.43

2546

22554

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

1372

0.62

4.86

1.3

1.8

0.86

0.79

nmol/l

0.36

1122

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

281

3489

0.76

4.85

1.5

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

385

2907

1.27

4.83

3.7

3.5

24.42

24.48

mmol/l

0.11

368

2835

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

5419

49453

1.10

4.82

3.1

2.9

46.49

40.17

u/l

4.57

4924

45360

(3042631) Mycobacterium sp identified in Specimen

123

774

1.52

4.69

2.8

2.9

—

(3051611) Lipemic interference index of Serum or Plasma

124

785

1.51

4.61

2.6

3.1

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

2.76

4.57

2.1

2.0

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1786

18669

0.89

4.54

1.7

71661241.49

35504698.86

pmol/l

1.06

1415

15201

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

903

7467

1.17

4.51

1.4

1.5

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

4.21

4.51

1.3

1.1

—

(3022948) Iron [Moles/volume] in Serum or Plasma

1317

11194

1.14

4.48

2.2

2.3

12.22

12.86

umol/l

2.73

1215

10204

(3001893) Eosinophils/100 leukocytes in Pleural fluid

100

2.48

4.41

1.4

1.2

3.45

2.33

0.24

(3000850) Epithelial cells [#/volume] in Urine

1779

15418

1.12

4.40

2.5

8.37

7.44

e6/l

1.03

1563

13636

(3023323) Follitropin [Units/volume] in Serum or Plasma

433

3356

1.24

4.36

1.4

1.3

44.46

36.50

iu/l

4.42

368

2957

(3017354) Segmented neutrophils/100 leukocytes in Blood

567

1.58

4.35

3.3

2.6

57.67

59.03

0.23

465

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

3089

31323

0.91

4.30

4.3

4.4

—

(3033799) Differential panel - Peritoneal fluid

113

2.36

4.30

2.0

2.2

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

289

1.82

4.23

1.3

1.4

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

283

1.82

4.19

1.3

1.4

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

492

3888

1.22

4.13

1.4

1.5

—

(3018834) Bilirubin.total [Presence] in Urine by Test strip

5.96

4.12

3.3

1.1

—

(3026008) Bacteria identified in Urine by Culture

3293

29530

1.09

4.10

3.3

—

(3000494) Fungus identified in Specimen by Culture

1074

9077

1.14

3.98

1.4

—

(3017181) Myelocytes/100 leukocytes in Blood

730

6000

1.17

3.96

3.7

3.9

1.43

0.73

7.19

315

1382

(3022145) Colonoscopy Study observation

1017

8571

1.14

3.93

1.3

1.2

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

149

2.11

3.92

1.1

1.2

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

987

0.61

3.90

1.1

109.05

12557.50

iu/ml

0.54

190

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

2.89

3.87

1.4

1.2

—

(3008898) HLA-B27 [Presence]

216

2686

0.76

3.85

1.1

—

(3029937) Albumin [Presence] in Urine by Test strip

2144

22018

0.91

3.83

4.5

0.00

estimate

0.14

742

7041

(3008295) Osmolality of Serum or Plasma

115

748

1.47

3.82

1.4

1.5

275.74

273.90

mosm/kgh2o

0.39

559

(40761535) Cells panel - Urine sediment

628

6962

0.85

3.79

3.6

—

(44786800) Granulocytes/100 leukocytes in Body fluid

3.18

3.71

1.2

1.3

26.93

25.91

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

3.68

0.0

1.1

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

442

1.60

3.64

1.7

1.6

—

(3011544) Albumin [Mass/volume] in Pleural fluid

3.76

3.59

1.3

1.1

15.52

14.18

g/l

0.25

(3037692) Legionella sp identified in Specimen by Organism specific culture

184

1.92

3.43

1.1

1.3

—

(3028271) Lactate [Moles/volume] in Capillary blood

150

1047

1.37

3.41

1.8

1.7

1.70

1.67

mmol/l

0.16

144

1027

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

195

2412

0.77

3.39

1.5

8.30

8.27

iu/ml

0.00

520

(3012501) Base excess in Blood by calculation

198

1443

1.31

3.38

3.2

3.5

2.76

2.72

mmol/l

0.07

154

1019

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

103

674

1.46

3.37

5.0

6.3

11.87

12.36

mg/l

0.59

602

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

133

2.08

3.36

2.0

4901.64

28506.78

e6/l

0.75

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

1262

0.68

3.27

1.1

0.87

1.41

u/ml

0.70

596

(40761511) CBC panel - Blood by Automated count

8787

82554

1.12

3.25

14.9

11.7

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

411

4656

0.83

3.23

1.8

—

(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine

4.77

3.22

1.0

352.00

195.85

u/l

—

(40758292) HTLV I+II Ab panel - Serum

3.57

3.21

1.2

1.3

—

(3019832) Treponema pallidum Ab [Presence] in Serum

312

3624

0.81

3.19

1.5

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

141

988

1.36

3.16

1.3

—

(1761868) Lipid panel - Serum or Plasma

2642

26683

0.92

3.15

2.9

3.0

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

188

1378

1.31

3.11

2.9

3.3

58.71

57.35

0.65

188

1378

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

690

5763

1.15

3.08

3.0

2.9

4.37

4.41

pmol/l

0.60

614

4997

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

154

1099

1.34

3.07

2.1

2.0

25.95

25.20

mg/l

0.05

278

(3015171) Extractable nuclear Ab [Units/volume] in Serum

345

3946

0.83

3.03

1.2

1.3

2.18

0.69

u/ml

0.65

367

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

175

2157

0.77

3.00

1.6

1.8

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

127

884

1.37

2.98

1.3

121.97

123.08

u/ml

0.02

205

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1882

19217

0.92

2.89

1.3

1.78

1.40

u/ml

0.41

431

5136

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

180

1327

1.30

2.88

1.5

1.7

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

334

1.60

2.85

2.3

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

467

3813

1.17

2.84

3.3

3.2

2.13

2.10

mmol/l

0.07

362

2917

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

3.67

2.83

1.5

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

335

1.60

2.82

1.4

1.3

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

335

1.60

2.82

1.4

1.3

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1727

15277

1.09

2.81

3.5

3.7

122.84

305.06

ng/l

6.10

1344

11547

(3022689) Creatine [Moles/volume] in Urine

261

0.36

2.81

1.4

1.6

—

(3002032) Base excess in Venous blood by calculation

731

6181

1.14

2.76

3.3

2.00

2.20

mmol/l

0.81

634

5378

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

320

2536

1.21

2.73

3.6

3.5

25.19

25.22

mmol/l

0.07

294

2286

(3003338) MCHC [Mass/volume]

6813

66305

0.93

2.73

21.8

16.0

329.94

330.44

g/l

5.47

6761

65801

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

2.62

2.71

1.0

2.1

—

(3005322) IgE [Units/volume] in Serum or Plasma

476

5229

0.86

2.64

1.3

130.04

181.40

u/ml

2.26

433

4817

(3002179) Metamyelocytes/100 leukocytes in Blood

660

5569

1.14

2.59

3.7

1.11

0.55

4.67

265

1241

(3010421) pH of Blood

222

1705

1.25

2.58

3.1

3.3

7.42

0.39

212

1560

(3013139) Helicobacter pylori Ag [Presence] in Stool

608

6553

0.88

2.58

1.2

1.3

—

(3023520) Reticulocytes [#/volume] in Blood

638

5374

1.14

2.57

2.3

2.2

69.64

71.14

e9/l

0.46

467

4056

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

289

0.43

2.55

5.9

10.4

854.77

814.83

nmol/l

0.09

277

(3037467) Urinalysis macro (dipstick) panel - Urine

6076

56405

1.07

2.55

4.7

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

988

0.69

2.53

1.2

1.3

7.47

7.50

mmol/l

0.03

849

(3025468) Yersinia sp identified in Specimen by Organism specific culture

137

996

1.31

2.48

1.6

1.3

—

(3009343) pH of Capillary blood

477

3952

1.16

2.45

3.3

7.43

7.42

2.07

504

(21494434) Karyotype in Bone marrow

448

1.47

2.45

1.1

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

5.20

2.44

3.0

1.1

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

3.81

2.44

1.1

—

(3025130) Human papilloma virus identified in Specimen

176

1326

1.27

2.43

1.7

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

418

1.48

2.42

1.0

1.1

—

(40767503) Oxygen content in Capillary blood by calculation

179

1355

1.26

2.39

2.5

2.4

16.22

16.19

0.02

663

(3021447) Carbon dioxide [Partial pressure] in Venous blood

725

6190

1.12

2.37

3.3

5.81

5.87

kpa

0.81

700

6005

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

369

4094

0.85

2.36

1.8

1.7

—

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

132

1.88

2.36

1.7

1.5

71.37

71.47

0.01

127

(3022313) Gas panel - Capillary blood

352

2861

1.18

2.32

3.4

3.3

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

422

1.47

2.32

1.0

1.1

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

154

1.80

2.30

1.1

—

(3048689) Calprotectin [Mass/mass] in Stool

995

10351

0.91

2.30

1.9

2.0

141.29

117.60

ug/g

0.45

762

7930

(4200892) Spirometry reversibility

595

6368

0.88

2.29

1.4

1.5

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

1122

0.73

2.28

1.1

5.62

2.76

u/ml

0.49

507

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

127

1.88

2.27

1.0

1.1

—

(3037522) Nuclear Ab [Titer] in Serum

1180

12169

0.91

2.27

1.3

1.4

489.68

610.51

titre

1.73

285

2869

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

137

1011

1.29

2.26

1.6

1.3

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

135

995

1.30

2.25

1.6

1.3

—

(3021440) Promyelocytes/100 leukocytes in Blood

682

5824

1.12

2.24

3.9

0.27

0.06

4.88

270

1208

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

479

4002

1.15

2.22

3.3

5.21

5.24

kpa

0.32

451

3736

(3025577) Chromium [Mass/volume] in Blood

529

0.61

2.21

2.1

1.71

2.88

ug/l

3.63

443

(3049717) Cytology report of Urine Cyto stain

224

1757

1.22

2.19

2.3

1.8

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

135

1000

1.29

2.17

1.6

1.3

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

308

0.49

2.17

1.1

1927.56

1573.76

miu/ml

0.51

308

(3008536) Aspergillus sp Ab [Presence] in Serum

2.04

2.16

3.1

1.5

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

136

1010

1.29

2.15

1.1

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

461

1.43

2.15

1.1

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

3.31

2.15

1.0

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

1086

0.73

2.13

1.1

1.32

0.80

u/ml

0.38

408

(43055514) Macroprolactin [Presence] in Serum or Plasma

104

1.93

2.07

1.4

1.5

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

136

1017

1.28

2.06

1.6

1.3

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

467

1.41

2.02

1.3

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

2.05

1.99

1.0

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

962

0.73

1.97

1.0

1.1

0.43

0.94

u/ml

1.53

447

(3005719) IgG [Mass/volume] in Serum or Plasma

615

5271

1.12

1.94

3.0

2.5

9.87

10.50

g/l

3.00

555

4793

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

2.03

1.93

1.0

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

2.03

1.93

1.0

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

658

0.68

1.92

1.3

1.2

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

473

1.39

1.90

1.3

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

138

1046

1.26

1.89

1.6

1.3

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

457

3853

1.14

1.89

1.3

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

830

8620

0.91

1.88

1.6

—

(3000492) Spirometry study

815

7105

1.10

1.87

1.4

1.5

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

459

0.62

1.87

1.2

1.5

—

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

130

1.76

1.83

1.8

1.5

412.96

531.07

mu/l

0.67

125

(3014133) Dog dander IgE Ab [Units/volume] in Serum

850

0.73

1.82

1.0

1.1

4.83

2.67

u/ml

0.53

368

(1001926) Buprenorphine [Presence] in Urine by Screen method

1046

0.75

1.82

2.6

1.5

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

794

0.72

1.81

1.0

1.1

4.16

2.95

u/ml

0.21

294

(3009466) Valproate [Moles/volume] in Serum or Plasma

1043

0.76

1.79

3.9

4.9

362.99

373.62

umol/l

0.30

895

(3005082) Progesterone [Moles/volume] in Serum or Plasma

159

0.42

1.78

1.1

1.3

22.02

27.56

nmol/l

—

132

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

813

0.72

1.77

2.0

1.5

38.78

33.06

0.53

465

(3003181) Sodium [Moles/volume] in Urine

200

1591

1.20

1.76

1.4

66.23

61.71

mmol/l

0.67

154

1267

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

179

1409

1.21

1.76

1.5

1.6

—

(3028026) IgM [Mass/volume] in Serum or Plasma

483

4109

1.13

1.76

1.8

1.5

1.23

1.28

g/l

0.27

434

3715

(3016879) Cocaine [Presence] in Urine

101

1232

0.78

1.74

2.3

1.6

—

(3003740) Influenza virus B Ag [Presence] in Specimen

116

872

1.27

1.73

1.0

1.1

—

(3000093) Morphology [Interpretation] in Blood Narrative

539

1.35

1.73

1.1

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

275

1.49

1.73

1.3

69.09

74.82

nmol/24h

0.25

275

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

112

1347

0.79

1.73

1.3

1.5

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

663

1.31

1.73

1.3

1.2

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

561

0.68

1.69

1.4

1.7

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

695

0.71

1.69

1.0

0.86

0.28

u/ml

0.43

181

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

452

1.37

1.68

2.1

1.5

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

2.63

1.68

2.4

1.1

—

(3004775) Volume in Urine collected for unspecified duration

549

0.68

1.68

2.0

2.3

631.21

622.91

0.04

394

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

265

2923

0.86

1.66

1.5

1.7

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

228

2542

0.85

1.65

1.3

2.91

6.34

u/ml

0.81

289

(3016650) Hepatitis A virus Ab [Presence] in Serum

130

999

1.24

1.63

1.1

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

232

2579

0.85

1.62

1.3

9.66

6.99

u/ml

0.30

461

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.88

1.62

1.1

1.0

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

2.54

1.62

1.1

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

678

0.71

1.61

1.1

1.5

—

(3002523) Influenza virus A Ag [Presence] in Specimen

115

873

1.26

1.61

1.0

1.1

—

(3000012) Reticulocyte production index

108

814

1.27

1.60

2.0

1.8

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

2.23

1.59

1.3

1.1

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

250

1.49

1.58

1.6

2.04

2.02

umol/l

0.07

233

(3041918) Cholesterol [Moles/volume] in Pleural fluid

1.83

1.57

1.1

1.2

1.91

1.76

mmol/l

0.13

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

180

1437

1.20

1.57

2.2

2.7

1.47

1.56

mg/l

0.82

157

1286

(3002621) Streptococcal DNAse B [Units/volume] in Serum

2.12

1.55

1.1

1.0

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

259

2843

0.86

1.55

1.6

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

314

3398

0.88

1.53

1.7

1.6

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

412

1.37

1.52

1.1

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

257

2817

0.87

1.51

1.2

1.3

31.21

46.08

u/ml

0.49

181

(3035320) C reactive protein [Mass/volume] in Body fluid

594

1.30

1.51

2.2

2.5

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

268

0.57

1.47

1.3

1.2

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

383

0.65

1.44

1.3

1.5

1.04

1.27

nmol/l

0.74

309

(3006270) Folate [Moles/volume] in Blood

742

1.26

1.43

1.2

331.94

361.36

nmol/l

0.75

618

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

100

759

1.26

1.43

1.9

1.6

32.49

31.96

0.56

100

751

(3011288) Drugs identified in Urine by Screen method

910

0.77

1.42

1.8

2.0

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

2.47

1.42

1.0

1.4

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

320

1.40

1.42

3.1

2.1

489.05

557.40

e6/l

0.22

269

(3001019) Free T4 and TSH panel - Serum or Plasma

382

4060

0.89

1.42

1.8

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.82

1.39

1.1

1.0

—

(3037756) Immunofixation for Serum or Plasma

166

1333

1.19

1.39

1.6

1.3

—

(3025159) Blasts/100 leukocytes in Blood

640

5608

1.09

1.38

3.8

3.9

0.58

0.06

0.64

222

1032

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

333

0.63

1.38

1.2

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

644

5647

1.09

1.37

1.3

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

2.38

1.36

1.0

1.5

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

1.94

1.36

1.5

—

(3000764) Benzodiazepines [Presence] in Urine

116

1346

0.82

1.36

2.2

1.6

—

(3028300) Cannabinoids [Presence] in Urine

117

1356

0.82

1.35

2.2

1.6

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

2.60

1.35

1.0

—

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

0.00

1.34

0.0

1.0

—

1.93

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

621

0.73

1.34

1.1

1.2

30.00

194.96

titre

—

113

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

204

2249

0.86

1.33

1.7

1.4

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

190

2106

0.86

1.33

1.3

1.07

6.64

u/ml

2.15

159

(3007916) DNA double strand Ab [Titer] in Serum

141

0.47

1.31

1.1

1.3

—

214.19

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

619

0.74

1.31

1.1

1.2

—

143.00

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

270

0.60

1.31

1.9

1.6

9.41

8.70

ug/l

0.31

270

(3027008) Opiates [Presence] in Urine

117

1350

0.82

1.30

2.2

1.6

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

640

0.74

1.30

1.0

1.1

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

474

0.70

1.29

1.1

—

(3023183) Ammonium ion [Moles/volume] in Plasma

138

1099

1.20

1.29

2.9

2.6

34.22

32.23

umol/l

0.51

116

979

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

241

2616

0.87

1.28

1.3

1.7

1.17

1.20

g/l

1.03

228

2468

(3000285) Sodium [Moles/volume] in Blood

126

0.45

1.28

1.5

1.3

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

594

0.74

1.28

1.2

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

155

1249

1.18

1.27

1.2

0.15

0.26

nmol/l

1.62

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

303

1.38

1.27

3.3

2.2

0.23

0.21

e9/l

0.20

263

(3014148) Varicella zoster virus Ab [Titer] in Serum

734

0.76

1.27

1.1

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

279

0.61

1.27

1.1

1.2

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

721

1.24

1.27

2.1

2.2

2.49

2.91

u/field

0.20

259

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

625

0.75

1.26

1.0

47.14

48.72

ng/l

0.09

429

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

733

0.77

1.26

1.0

1.1

—

72.11

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

237

2571

0.87

1.25

1.3

1.7

0.23

g/l

0.09

222

2426

(3028626) Oxygen [Partial pressure] in Capillary blood

157

1269

1.18

1.25

2.5

2.7

8.20

8.13

kpa

0.25

149

1244

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

590

0.74

1.23

1.2

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

217

1.45

1.23

2.6

1.8

165.45

163.02

0.04

199

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

127

1009

1.20

1.23

1.1

1.2

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

142

1140

1.19

1.23

1.2

—

(3019060) Gas panel - Arterial blood

495

4316

1.10

1.22

3.9

4.2

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

207

2261

0.87

1.22

1.5

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

192

0.55

1.21

1.3

1.7

—

84.95

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

266

1.40

1.20

1.1

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1211

10934

1.06

1.20

4.7

4.8

34.19

33.56

1.21

755

7262

(3027944) Amphetamines [Presence] in Urine

116

1326

0.83

1.20

2.2

1.6

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

366

0.68

1.20

1.0

1.1

1.23

1.06

u/l

0.47

174

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

270

2281

1.13

1.19

1.9

2.1

367.74

586.34

ug/l

1.06

236

2113

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

120

953

1.20

1.18

1.1

1.2

290.99

290.69

u/ml

0.00

605

(3021901) Oxygen saturation in Capillary blood

135

1085

1.19

1.17

2.6

2.7

—

(3026726) Creatinine [Moles/volume] in Specimen

2.29

1.16

1.2

4.1

48.50

269.08

umol/l

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

180

1483

1.16

1.15

1.2

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

615

0.76

1.15

1.0

1067.20

352.15

ng/l

0.47

429

(3024354) Oxygen [Partial pressure] in Venous blood

594

5241

1.08

1.14

2.8

4.54

4.45

kpa

0.46

572

5081

(3024869) Neuronal Ab [Presence] in Serum

105

1.63

1.13

1.1

1.0

—

(3013293) Extractable nuclear Ab [Presence] in Serum

187

0.56

1.12

1.3

1.5

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

449

0.72

1.12

1.7

1.5

3.36

4.39

0.21

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

461

1.28

1.11

2.3

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

1.68

1.10

1.2

1.3

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

621

0.77

1.10

1.0

726.72

714.87

ng/l

0.06

416

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

381

0.70

1.10

1.8

1.6

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

645

6591

0.93

1.10

2.1

2.3

5.02

5.76

ug/l

0.69

518

5561

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

2.22

1.09

9.6

1.0

—

(3001729) Color of Synovial fluid

1.77

1.08

2.5

1.7

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

1092

0.83

1.07

1.3

1.2

—

(3004616) Nuclear Ab [Presence] in Serum

108

1226

0.84

1.06

1.3

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

209

1753

1.14

1.06

1.5

1.3

—

(3022621) pH of Urine by Test strip

573

5873

0.92

1.06

3.8

3.2

—

(3028707) Methadone [Presence] in Urine by Screen method

638

0.78

1.05

3.4

1.8

—

(3029075) Extractable nuclear Ab panel - Serum

241

1.38

1.05

1.1

—

(3047189) Immunofixation for 24 hour Urine

185

1.44

1.05

1.4

1.2

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

243

2593

0.89

1.04

1.6

135.38

295.23

titre

2.52

154

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

123

1.55

1.04

1.1

1.0

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

335

2894

1.11

1.04

1.6

1.62

g/l

0.01

271

2454

(3008116) Ketones [Moles/volume] in Urine by Test strip

143

0.53

1.03

1.0

1.4

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

103

0.46

1.01

12.2

8.1

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

1.62

1.00

1.4

2.2

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

384

3990

0.91

1.00

1.3

1.4

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

2622

25702

0.96

0.99

2.0

147.11

169.55

u/l

1.33

2440

23798

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

2107

19401

1.04

0.99

2.2

2.3

3.04

2.98

mg/l

0.41

1728

16470

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

664

6744

0.93

0.98

1.6

1.40

1.38

0.14

561

5853

(3024980) IgG subclass 4 [Mass/volume] in Serum

109

1223

0.85

0.96

1.3

1.5

0.55

0.67

g/l

1.20

922

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

429

4427

0.92

0.96

1.0

1.1

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

362

1.29

0.95

1.4

1.6

3.51

4.30

nmol/l

0.18

293

(3035350) Ketones [Presence] in Urine by Test strip

4201

40792

0.97

0.94

4.0

4.1

0.00

estimate

0.22

810

7670

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

190

1.40

0.93

2.1

2.5

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

1.65

0.93

1.0

1.1

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

1.65

0.93

1.2

1.6

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

1.83

0.93

1.7

1.8

—

(3026493) Urate [Moles/volume] in Serum or Plasma

1977

19451

0.96

0.90

2.4

2.1

5744.26

4784.86

umol/l

0.44

1678

16575

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

196

2095

0.89

0.90

1.2

1.3

35.15

49.22

u/ml

0.76

230

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

419

0.75

0.89

1.1

—

(3006245) CD3-CD19+ cells/100 cells in Blood

152

1.44

0.89

1.3

2.0

13.56

8.46

1.45

142

(3016750) Collection duration of Urine

396

0.74

0.87

2.0

2.2

483.67

503.03

min

0.70

312

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.86

0.87

1.1

1.0

—

(3009871) Measles virus Ab [Titer] in Serum

241

0.67

0.87

1.4

1.7

—

(3010838) Calcium [Moles/time] in 24 hour Urine

216

1845

1.12

0.87

1.7

1.9

5.46

5.06

mmol/24h

0.90

185

1600

(1002224) Polysomnography panel

262

2749

0.91

0.87

1.1

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

188

1593

1.13

0.86

2.2

2.1

128.51

127.78

g/l

0.14

121

1143

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

796

0.82

0.86

1.3

1.2

8.29

48.19

u/ml

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

1.97

0.85

3.7

3.2

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

1.97

0.85

1.0

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

636

1.20

0.85

3.8

3.7

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

3289

30644

1.03

0.83

3.6

3.5

32.51

56.82

ng/l

1.43

2253

19989

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

1.91

0.83

1.2

1.0

—

(3040151) Glucose [Moles/volume] in Capillary blood

753

1.18

0.81

6.0

9.4

7.02

7.54

mmol/l

0.65

613

(3019977) pH of Arterial blood

329

1.27

0.81

2.6

2.4

7.42

0.02

112

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

780

0.83

0.81

1.0

1.1

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

486

0.78

0.80

1.2

1.1

234.94

246.17

mg/l

0.25

428

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1098

10910

0.95

0.80

7.1

6.4

—

(3051593) INR in Capillary blood by Coagulation assay

364

1.26

0.80

9.0

10.1

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

0.00

0.79

0.0

2.6

—

(3020650) Glucose [Presence] in Urine

179

0.64

0.79

1.0

1.5

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

0.78

0.0

1.0

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

0.51

0.78

1.0

1.1

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

102

1125

0.86

0.78

1.8

1.6

57.08

54.68

0.27

686

(3003327) Ova and parasites identified in Stool by Light microscopy

277

2877

0.91

0.77

1.6

1.7

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

299

1.28

0.75

1.5

1.4

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

436

1.22

0.75

1.2

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

102

1.49

0.75

1.1

1.4

1418189.87

368360.86

nmol/l

0.49

(46235355) HIV 1 and 2 tests - Meaningful Use set

919

8365

1.05

0.75

1.6

—

(3017704) Immunofixation for Urine

363

0.76

0.74

1.9

1.2

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

585

0.81

0.74

1.5

1.3

1.54

1.44

nmol/l

0.23

525

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

2.07

0.74

1.0

—

(3050129) First trimester maternal screen panel - Serum or Plasma

894

0.85

0.73

1.4

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

208

1795

1.11

0.73

3.3

3.4

0.81

0.82

nmol/l

0.08

163

1429

(3026389) Candida sp identified in Specimen by Organism specific culture

139

1492

0.89

0.73

1.4

—

(3020874) Milk IgE Ab [Units/volume] in Serum

415

0.78

0.73

1.0

0.38

1.08

u/ml

—

134

(3016018) Differential panel - Cerebral spinal fluid

789

1.16

0.72

1.5

—

(44813793) Dust mix specific IgE antibody measurement

645

0.83

0.72

1.1

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

810

0.85

0.72

1.3

1.5

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

115

1248

0.88

0.72

1.6

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

156

1660

0.89

0.71

1.2

3.55

3.75

mmol/l

1.38

145

1559

(3036071) Salmonella sp Ab [Titer] in Serum

201

1.33

0.71

1.1

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

460

4113

1.07

0.70

6.2

6.3

25.07

24.87

mmol/l

0.58

445

3905

(3035933) Granulocytes/100 leukocytes in Blood

144

1.39

0.70

1.2

1.8

—

(3044927) Protein electrophoresis panel - Urine

828

0.85

0.70

1.1

1.2

—

(3037121) Protein [Mass/volume] in Urine

272

2386

1.09

0.69

2.9

2.4

0.16

0.33

g/l

6.64

625

(1616796) Gas panel - Central venous blood

157

1340

1.12

0.69

3.2

3.3

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

2382

23233

0.97

0.69

1.6

1.30

1.33

mmol/l

1.84

1958

19370

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

1.64

0.68

3.0

1.3

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

1.83

0.67

1.2

1.4

308.24

547.64

nmol/l

—

(3021960) Folate [Moles/volume] in Serum or Plasma

2112

19605

1.03

0.67

1.5

21.85

21.86

nmol/l

0.01

1723

16313

(3028679) Herpes simplex virus Ab [Presence] in Serum

322

1.24

0.67

1.3

1.2

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

365

1.23

0.67

1.1

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

1.63

0.66

1.1

1.2

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

187

1.32

0.66

1.1

1.3

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

182

0.68

0.66

1.2

1.4

91.50

129.35

nmol/l

—

120

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

248

0.73

0.66

1.1

—

(3020961) Endomysium IgA Ab [Titer] in Serum

392

3983

0.93

0.66

1.1

489.67

193.36

titre

1.01

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

157

1660

0.90

0.66

1.5

1.4

712.97

1351.71

e6/l

0.82

117

1375

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

157

1658

0.90

0.64

1.4

26.12

33.18

e6/l

0.21

105

1302

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

163

1.34

0.64

5.0

2.4

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

203

0.70

0.64

1.4

1.1

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

298

1.25

0.64

1.1

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

105

879

1.14

0.64

1.1

1.52

1.47

g/l

0.70

781

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

124

0.61

0.63

2.8

1.8

13.11

18.11

umol/l

—

124

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

870

0.86

0.63

1.0

—

(40757373) Influenza virus identified in Isolate

123

1.39

0.62

1.2

1.4

—

(3024928) Oxygen saturation in Venous blood

158

1359

1.11

0.62

2.2

3.0

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

797

0.86

0.62

1.2

1.5

6.36

6.70

g/l

0.35

566

(3044242) Glucose [Moles/volume] in Arterial blood

283

1.25

0.61

2.2

2.0

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

796

0.86

0.61

1.2

1.5

0.43

0.40

g/l

0.20

567

(3036603) Volume of Urine

466

1.19

0.60

1.3

1.4

1670.55

1855.01

0.91

443

(3028192) IgG subclass 2 [Mass/volume] in Serum

795

0.86

0.60

1.2

1.5

2.63

2.88

g/l

0.72

563

(3010937) Rubella virus Ab [Presence] in Serum

1.64

0.60

1.0

1.1

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

600

0.84

0.60

1.8

1.7

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

397

1.20

0.59

1.2

1.1

—

(3032868) Hemoglobin electrophoresis panel in Blood

1.52

0.59

1.5

—

(3001556) Androgen free Index in Serum or Plasma

0.00

0.58

0.0

1.1

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

125

1.37

0.58

1.0

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.73

0.58

1.0

—

(3020891) Body temperature

304

2704

1.07

0.58

4.1

4.3

—

(3043409) Potassium [Moles/volume] in Arterial blood

230

2024

1.08

0.58

3.8

4.0

3.82

3.80

mmol/l

0.21

230

2012

(4062490) Immunoglobulin typing, IgG

791

0.87

0.57

1.2

1.5

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

260

1.25

0.57

1.1

1.4

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

260

1.25

0.57

1.1

1.4

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

176

0.70

0.57

1.0

1.8

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

252

0.76

0.57

1.0

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

410

0.81

0.57

1.1

1.2

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

219

0.74

0.56

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

219

0.74

0.56

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

219

0.74

0.56

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

219

0.74

0.56

1.1

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

382

1.20

0.56

1.6

1.9

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

1002

0.88

0.56

1.2

28.90

23.93

u/l

0.38

866

(3039162) Centromere protein B Ab [Units/volume] in Serum

119

1263

0.90

0.56

1.2

1.3

70.57

60.45

u/ml

—

100

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

0.56

1.0

0.01

1.18

u/ml

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1393

12893

1.03

0.55

1.4

—

(3012565) Volume of 24 hour Urine

331

1.21

0.55

1.8

1.6

1937.86

1870.59

0.15

292

(3002619) Bacteria identified in Specimen by Culture

160

1.31

0.54

1.1

1.3

—

(4212803) Bone marrow aspirate examination

1.50

0.54

1.0

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

130

1368

0.90

0.53

1.2

—

(3036180) Methadone [Presence] in Urine

173

0.72

0.53

1.0

1.4

—

(3017732) Neutrophils [#/volume] in Blood

611

5568

1.05

0.53

3.0

2.7

3.74

4.75

e9/l

5.56

479

4282

(3012494) Peanut IgE Ab [Units/volume] in Serum

216

0.75

0.52

1.0

0.30

1.00

u/ml

—

107

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

1.40

0.52

1.1

1.2

20.04

77.26

ng/l

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

1.50

0.51

1.2

1.0

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

620

0.86

0.51

1.6

1.7

8.33

7.02

umol/l

0.22

442

(3000034) Microalbumin [Mass/volume] in Urine

751

0.87

0.50

2.4

2.9

22.50

36.82

mg/l

0.50

499

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

751

0.87

0.50

1.3

1.2

2.44

10.52

u/ml

—

(3014051) Protein [Presence] in Urine by Test strip

263

2343

1.07

0.50

2.8

2.5

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

117

1006

1.11

0.50

1.1

124.23

124.08

0.01

103

896

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

530

1.15

0.49

1.0

—

(3004588) Protein electrophoresis panel - Serum or Plasma

561

5116

1.05

0.49

2.2

1.5

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

266

0.79

0.48

1.2

0.30

0.31

g/l

0.41

221

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

442

1.16

0.48

1.9

2.0

0.92

2.49

u/field

2.36

286

(4094501) Cardiovascular stress test using bicycle ergometer

221

2258

0.93

0.48

1.1

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

121

1045

1.10

0.48

1.2

1.3

489.61

300.34

pmol/l

0.42

107

919

(3011397) Hemoglobin [Presence] in Urine by Test strip

2064

20058

0.97

0.48

3.9

4.1

—

(3043410) Blood group antigens tested for on Red Blood Cells

147

1.30

0.47

1.5

1.6

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

158

0.72

0.47

1.0

1.1

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

716

0.88

0.47

1.5

1.4

—

3.83

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

207

1.24

0.47

1.1

1.0

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

426

1.16

0.47

1.5

1.4

1.65

1.63

g/l

0.17

426

(3015183) Erythrocyte sedimentation rate

329

1.19

0.46

1.2

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

430

0.84

0.46

1.3

1.5

0.82

1.14

promille

0.92

310

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

0.60

0.45

1.4

1.1

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

624

6175

0.96

0.45

1.2

146.28

146.26

iu/ml

0.00

227

2458

(3025018) Bordetella pertussis Ab [Titer] in Serum

489

0.86

0.44

1.1

1.3

—

(3009261) Glucose [Presence] in Urine by Test strip

4283

41244

0.98

0.44

4.1

0.00

estimate

2.04

760

7024

(3014599) Egg white IgE Ab [Units/volume] in Serum

407

0.84

0.44

1.0

0.61

0.60

u/ml

0.01

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

250

0.80

0.42

1.2

1.1

109.33

115.26

0.41

218

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

133

1165

1.09

0.42

1.1

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

100

864

1.10

0.42

1.5

1.4

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

124

1083

1.09

0.41

1.2

3.14

3.40

u/ml

0.09

368

(3034614) HLA Ag [Interpretation]

0.00

0.41

0.0

1.1

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

0.41

0.0

1.1

—

(3021367) Citalopram [Moles/volume] in Serum or Plasma

0.00

0.41

0.0

1.4

—

116.00

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

379

1.16

0.40

1.1

1.0

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

748

1.11

0.40

1.1

93.51

94.07

0.07

700

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

174

0.77

0.40

1.2

1.1

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

745

0.89

0.39

1.3

1.4

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

330

0.84

0.39

1.0

0.08

0.28

u/ml

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

0.00

0.39

0.0

5.4

—

356.44

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

183

1862

0.93

0.39

1.3

240.44

222.08

miu/ml

0.26

896

(21494890) Protein electrophoresis panel - 24 hour Urine

579

1.12

0.38

1.6

1.3

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

1.34

0.38

1.0

1.1

—

(3011897) Casein IgE Ab [Units/volume] in Serum

107

0.71

0.37

1.4

1.1

0.10

0.65

u/ml

—

107

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

109

0.70

0.37

1.4

1.1

1.72

1.58

umol/24h

—

109

(3021601) Nitrite [Presence] in Urine by Test strip

4249

40859

0.98

0.36

5.4

0.00

estimate

0.19

749

6982

(3017569) Oxygen content in Arterial blood

294

1.17

0.36

2.4

2.1

—

(3025941) Bacteria identified in Stool by Culture

499

4581

1.04

0.36

1.2

1.3

—

(40768446) Kidney Pathology biopsy report

192

0.79

0.36

1.8

1.5

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

1.26

0.36

11.6

11.3

3.92

4.48

mmol/l

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

555

1.12

0.35

1.2

1.4

2.39

2.18

mmol/l

0.46

515

(3018851) Theophylline [Moles/volume] in Serum or Plasma

1.38

0.35

1.3

1.8

83.50

47.12

umol/l

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

163

1.23

0.35

1.1

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

186

1882

0.94

0.35

1.3

548.27

508.21

mg/l

0.37

176

1777

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

748

0.90

0.35

1.3

1.4

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

311

2828

1.05

0.35

4.1

4.2

0.89

0.06

298

2641

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

181

1621

1.06

0.34

2.3

2.5

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

581

5355

1.04

0.34

1.3

59.53

51.39

au/ml

0.40

283

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

120

1059

1.08

0.34

1.1

4.35

3.65

u/ml

0.16

434

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

747

0.90

0.34

1.3

1.4

—

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

138

0.76

0.34

1.4

1.6

1.23

1.19

mmol/l

0.83

133

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

627

0.90

0.34

1.1

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

315

2868

1.05

0.34

4.1

4.2

1.54

1.61

0.79

302

2680

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.34

0.34

1.0

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

323

1.15

0.34

1.9

1.6

0.36

0.37

ug/l

0.10

204

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

188

1688

1.06

0.33

1.2

1.3

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

299

2721

1.05

0.33

1.6

1.7

2.78

3.64

mg/l

1.66

224

2003

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

745

0.91

0.33

1.3

1.4

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

121

1.26

0.33

1.0

92.31

79.02

ug/l

1.09

(3047007) Chlamydophila sp Ab [Presence] in Serum

128

1135

1.08

0.33

1.2

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

323

0.85

0.33

1.2

—

(3010375) cycloSPORINE [Mass/volume] in Blood

200

1.19

0.32

21.5

25.6

108.05

107.56

ug/l

0.01

164

(40762365) Oxygen content in Arterial blood by calculation

1.33

0.32

1.5

2.1

13.85

15.09

ml/dl

1.55

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

543

0.89

0.31

1.0

1.1

9.14

8.70

iu/ml

0.04

106

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

606

1.10

0.31

1.5

1.3

41.25

63.40

titre

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

301

0.85

0.31

1.0

1.1

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

1.36

0.31

1.0

1.2

—

(3020491) Glucose [Moles/volume] in Blood

542

0.90

0.30

1.4

2.0

6.15

6.89

mmol/l

2.67

367

(3019309) Folate [Moles/volume] in Red Blood Cells

1748

16386

1.02

0.30

1.8

1.7

1141.84

1194.56

nmol/l

1.44

1246

12156

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

381

1.13

0.30

1.4

1.2

—

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

145

0.79

0.29

1.1

114.67

111.37

0.10

139

(4146454) Self-monitoring of blood glucose

104

921

1.08

0.29

2.3

2.7

—

(3000963) Hemoglobin [Mass/volume] in Blood

9243

88191

0.97

0.29

24.8

18.1

130.17

132.69

g/l

73.37

9107

86571

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.32

0.28

1.0

1.2

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

288

0.86

0.28

2.7

2.6

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

619

1.09

0.28

1.5

1.3

152.00

502.40

titre

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

171

1542

1.06

0.28

2.6

2.8

25.78

25.41

mmol/l

0.55

162

1513

(3033923) Metanephrine [Moles/time] in 24 hour Urine

237

0.84

0.28

1.3

1.1

0.69

0.66

umol/24h

—

108

(3020876) Protein [Mass/time] in 24 hour Urine

620

1.09

0.28

2.3

1.9

0.65

1.00

g/24h

1.35

258

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.29

0.27

1.0

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

142

1.21

0.27

1.3

1.2

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

142

1.21

0.27

1.9

1.6

—

(3048879) Bone marrow aspiration report

151

1.20

0.27

2.5

1.3

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

330

1.13

0.27

1.4

1.3

0.77

1.22

nmol/l

3.12

265

(3041096) Erythrocytes [Presence] in Urine by Automated

2195

21159

0.98

0.26

3.7

—

(3010813) Leukocytes [#/volume] in Blood

9242

88169

0.97

0.26

24.7

18.0

6.36

6.52

e9/l

8.87

8988

85003

(3002079) Sodium [Moles/time] in 24 hour Urine

376

0.89

0.26

1.1

1.2

118.82

140.30

mmol/24h

1.41

376

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

633

5879

1.03

0.26

2.4

27.46

27.97

au/ml

0.04

438

(3051101) Glucose [Moles/volume] in Cord blood

163

0.82

0.26

4.4

5.6

—

(3015736) pH of Urine

3410

32762

0.99

0.26

3.6

3.8

5.86

5.89

0.21

240

2102

(3021788) Differential panel - Synovial fluid

161

1614

0.95

0.25

1.6

1.5

—

(3026361) Erythrocytes [#/volume] in Blood

9243

88175

0.97

0.25

24.7

18.0

4.34

4.42

e12/l

60.17

8987

85024

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

395

1.11

0.25

1.8

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

435

0.90

0.25

1.0

1.1

1.04

1.06

ratio

0.54

156

(3023419) Bacteria identified in Sputum by Culture

119

1069

1.06

0.24

2.5

2.8

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

0.73

0.24

1.3

1.1

—

(3011985) Renin [Units/volume] in Plasma

125

1125

1.06

0.24

1.4

68.60

50.99

mu/l

0.45

111

1004

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

240

2197

1.04

0.24

3.0

1.5

40.44

29.94

mg/l

0.66

187

1773

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

1.26

0.24

1.1

1.0

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

243

1.14

0.23

1.1

4.1

7355.00

69.30

mg/l

0.48

155

(3024731) MCV [Entitic volume]

9243

88166

0.98

0.23

24.6

17.9

91.58

91.12

20.63

9105

86528

(3045716) Anion gap in Serum or Plasma

325

1.11

0.23

3.6

2.3

9.57

9.72

mmol/l

0.11

318

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

1.29

0.23

1.0

1.1

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

1.25

0.22

1.2

1.3

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

391

0.90

0.22

1.0

1.1

—

(3035941) MCH [Entitic mass]

9243

88160

0.98

0.22

24.6

17.9

30.27

30.17

7.17

9104

86523

(3009445) Proteinase 3 Ab [Units/volume] in Serum

337

3310

0.97

0.22

1.3

1.5

8.60

15.04

u/ml

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

0.73

0.22

1.0

1.1

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

712

1.07

0.22

1.6

1.7

—

(40758047) Lysozyme [Mass/volume] in Pleural fluid

1.22

0.22

1.2

1.1

4.76

13.62

mg/l

—

(3052592) Norovirus Ag [Presence] in Stool

139

0.82

0.22

1.3

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

667

0.93

0.22

1.3

1.2

0.81

1.27

u/ml

0.33

368

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

588

0.92

0.21

1.4

1.3

—

10560.00

—

(3028433) Virus identified in Specimen by Culture

227

1.13

0.21

1.2

1.1

—

(3028714) Urate [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.0

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

0.00

0.21

0.0

1.2

—

(3003095) Rheumatoid factor [Units/volume] in Synovial fluid

0.00

0.21

0.0

1.0

—

(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

0.21

0.0

1.0

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

191

1.15

0.21

2.3

2.4

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

191

1.15

0.21

2.3

2.4

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

0.00

0.21

0.0

6.0

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

0.21

0.0

1.3

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.5

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

0.00

0.21

0.0

1.2

—

1.45

—

(3000060) B lymphocytes [#/volume] in Blood

111

1.20

0.21

1.3

2.1

472.00

139.57

e6/l

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

396

3873

0.97

0.20

1.5

1.4

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

211

2086

0.96

0.20

1.1

—

(3002719) Hemoglobin [Mass/volume] in Urine

0.00

0.20

0.0

1.2

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

240

2209

1.04

0.20

3.0

1.5

39.18

38.54

mg/l

0.04

184

1792

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

1.22

0.20

1.0

1.1

—

(1761482) Bacteria [#/volume] in Urine by Culture

237

2181

1.04

0.20

3.6

4.8

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

258

0.89

0.19

1.0

1.1

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

107

967

1.05

0.19

2.3

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

159

1452

1.04

0.19

1.9

4709.44

3963.67

u/l

0.12

578

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

116

1051

1.05

0.19

1.2

3.22

3.74

u/ml

0.32

441

(3044941) Cell count panel - Synovial fluid

136

1355

0.96

0.19

1.6

1.4

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

118

1070

1.05

0.19

1.1

—

(37021550) Renin [Units/volume] in Plasma --upright

175

1.14

0.19

1.0

1.3

169.18

60.52

mu/l

0.58

124

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

166

1.15

0.19

1.2

1.3

—

(3000475) Leukocytes [#/volume] in Synovial fluid

218

2149

0.97

0.19

1.9

1.6

13012.81

11701.73

e6/l

0.18

161

1553

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.24

0.19

1.1

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

187

0.87

0.19

1.4

1.5

—

(3036670) Protein [Mass/volume] in Synovial fluid

257

1.11

0.18

1.3

39.85

38.53

g/l

0.24

135

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

1.22

0.18

1.1

1.0

—

(3007461) Platelets [#/volume] in Blood

9241

88122

0.98

0.18

24.7

18.0

259.13

262.60

e9/l

5.70

9005

85285

(3011648) Oxygen content in Venous blood

497

1.07

0.18

1.7

2.2

9.97

10.81

0.77

497

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

196

0.87

0.17

1.0

1.1

2.31

9.88

u/ml

—

102

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

122

1111

1.05

0.17

1.2

—

nmol/l

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

473

0.93

0.17

1.1

1.0

—

(3047181) Lactate [Moles/volume] in Blood

229

2114

1.03

0.17

4.5

4.9

1.17

1.29

mmol/l

1.13

208

1852

(36660697) Celiac disease serology panel - Serum

741

6944

1.02

0.17

1.2

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

260

2406

1.03

0.17

2.1

1.5

0.76

0.38

g/l

1.16

212

2013

(3039000) Anion gap in Blood

155

1421

1.04

0.17

5.2

5.6

10.28

11.12

mmol/l

3.13

143

1263

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

0.72

0.17

1.0

1.1

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

175

0.87

0.17

1.0

1.1

—

(3004451) EKG impression Narrative

351

1.09

0.16

1.3

—

(3018572) Chloride [Moles/volume] in Blood

155

1422

1.04

0.16

5.2

5.6

105.24

104.53

mmol/l

1.18

143

1264

(3010144) Erythrocytes [#/volume] in Synovial fluid

813

0.95

0.16

1.9

1.4

78691.93

114888.51

e6/l

0.22

541

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

205

1.12

0.16

1.0

1.1

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

214

0.89

0.16

1.3

1.4

35.25

40.67

0.27

148

(3042733) HLA Ab [Presence] in Serum

144

0.86

0.16

4.5

4.8

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

0.79

0.15

1.0

—

(3006653) Thiamine [Moles/volume] in Blood

334

1.08

0.15

1.3

140.05

133.53

nmol/l

0.35

334

(40760888) Immunoglobulin light chains.free panel - Serum

174

1603

1.03

0.15

3.2

1.5

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

636

0.94

0.15

1.3

1.4

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

461

4307

1.02

0.15

2.6

3.0

123.82

128.18

g/l

4.81

453

4200

(3043238) Trisomy 21 risk [Likelihood] in Fetus

665

0.94

0.15

1.3

1.5

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

253

2473

0.97

0.15

1.3

1.4

279.77

295.21

ug/g

0.62

143

1388

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

188

1.11

0.15

1.0

1.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

179

1.12

0.14

1.0

1.1

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

0.80

0.14

4.4

6.7

—

(3016038) Potassium [Moles/volume] in Urine

605

1.06

0.14

1.2

1.1

37.95

33.04

mmol/l

1.14

489

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

212

0.90

0.14

1.3

1.4

76.45

90.41

ng/l

0.48

212

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

477

0.94

0.14

1.3

1.4

4.42

5.45

u/l

1.75

399

(3005033) Fetal Nuchal fold Thickness US

633

0.95

0.14

1.3

1.4

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

126

1243

0.96

0.13

1.6

—

(3044290) Cell count panel - Cerebral spinal fluid

157

1542

0.97

0.13

1.4

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

250

2438

0.98

0.13

1.2

—

(3024263) Appearance of Synovial fluid

430

1.06

0.13

1.7

1.4

—

(3000330) Specific gravity of Urine by Test strip

472

4422

1.02

0.13

3.2

3.7

—

(3026250) Tacrolimus [Mass/volume] in Blood

190

1.10

0.12

30.2

32.4

7.40

7.04

ug/l

0.48

170

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

190

1.10

0.12

1.0

1.1

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

181

1.11

0.12

1.0

1.1

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

246

1.08

0.12

1.0

1.1

90.00

92.50

0.14

109

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

356

3330

1.02

0.12

2.0

41.00

40.02

u/l

0.43

306

2935

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

595

5743

0.99

0.12

1.9

1.7

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

367

1.06

0.11

1.1

1.2

58.33

59.63

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

256

1.08

0.11

2.8

2.0

52.70

52.50

umol/l

0.01

207

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

252

2351

1.02

0.11

1.1

6.34

8.18

u/ml

0.32

237

(3038071) Oxygen [Partial pressure] in Mixed venous blood

109

1.14

0.11

9.3

6.5

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

109

1.14

0.11

1.0

1.2

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

238

1.08

0.11

1.0

1.1

96.50

94.65

0.08

109

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

564

1.05

0.11

1.1

1.0

312.98

297.46

mg/l

1.02

500

(42529406) Shigella sp [Presence] in Stool by Culture

254

2468

0.98

0.11

1.2

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

404

0.94

0.11

1.0

1.1

—

(3034426) Prothrombin time (PT)

218

0.92

0.10

1.1

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

210

1958

1.02

0.10

2.0

1.4

0.00

g/l

0.17

186

1759

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

276

0.93

0.10

1.1

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

315

0.94

0.10

2.9

2.0

275.95

123.81

umol/l

0.76

176

(21494567) Legionella sp IgM Ab [Presence] in Serum

1.08

0.09

1.0

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

1.08

0.09

1.0

—

(3023511) Choriogonadotropin [Units/volume] in Urine

801

1.03

0.09

1.7

1.3

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

1.06

0.09

1.4

1.2

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.06

0.09

1.0

1.2

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

226

2112

1.02

0.09

2.0

1.4

0.01

g/l

0.33

201

1905

(3013466) aPTT in Blood by Coagulation assay

1.04

0.09

1.0

1.1

34.48

37.15

—

(3014271) Vancomycin [Susceptibility]

436

1.05

0.09

3.1

3.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

254

2461

0.98

0.09

1.2

—

(3005011) Chlamydia sp Ab [Titer] in Serum

118

0.89

0.09

1.8

1.7

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

170

1585

1.02

0.08

1.8

1.7

333.92

332.51

mu/l

0.02

158

1406

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

1.04

0.08

1.0

1.3

—

17.79

—

(3023410) Appearance of Cerebral spinal fluid

728

0.97

0.08

1.8

1.5

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

438

1.04

0.08

1.3

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

307

1.05

0.08

1.1

98.46

95.70

0.20

232

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

949

0.97

0.08

1.1

—

(3006462) Nitrate [Presence] in Urine

420

1.04

0.07

3.8

3.5

—

(3028717) Thiamine [Mass/volume] in Blood

1.06

0.07

1.0

1.1

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

253

2375

1.01

0.07

1.8

4.44

16.55

iu/l

0.71

891

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

1.02

0.07

1.3

21.60

9.92

pmol/l

—

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

0.84

0.07

2.1

1.9

1.33

1.72

mg/l

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

206

1931

1.02

0.07

2.1

1.4

0.00

g/l

-0.00

184

1752

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

301

0.95

0.07

2.0

3.0

26.43

27.23

umol/l

0.14

232

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

228

2140

1.02

0.07

2.9

1.5

2.04

1.45

ratio

0.47

178

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

233

2251

0.99

0.07

1.3

1.4

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

159

1.08

0.06

1.2

—

(3032057) Clostridioides difficile [Presence] in Stool

194

0.93

0.06

2.4

1.5

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

725

0.97

0.06

1.6

18.00

22.95

u/ml

0.72

163

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

106

0.90

0.06

1.1

1.2

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

0.87

0.06

1.2

1.1

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

479

1.03

0.06

1.4

1.6

79.79

73.46

umol/l

0.34

479

(3024471) HLA-A [Type]

132

1.08

0.05

1.0

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

300

2888

0.99

0.05

1.9

1.4

7.61

7.60

g/l

0.04

260

2517

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

280

0.95

0.05

1.0

1.1

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

3584

34207

1.00

0.05

2.7

2.8

119.23

95.47

ug/l

5.85

3222

31335

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.10

0.05

1.0

—

(3009542) Hematocrit [Volume Fraction] of Blood

9241

88047

0.99

0.05

24.7

17.9

38.94

39.54

11.09

8720

81489

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

385

0.96

0.05

2.8

2.4

2217.18

766.82

u/ml

0.48

377

(3051387) C reactive protein [Mass/volume] in Capillary blood

182

1756

0.99

0.05

3.8

3.7

26.03

22.73

mg/l

0.51

106

1111

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

105

1.09

0.04

1.0

1.2

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

368

3477

1.01

0.04

2.9

3.0

25.52

25.70

mmol/l

0.52

359

3376

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

246

1.05

0.04

1.1

1.2

22.75

20.59

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

4872

46460

1.00

0.04

2.7

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

300

2881

0.99

0.04

1.9

1.4

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

162

0.94

0.04

1.1

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

300

2880

0.99

0.04

1.9

1.4

3.74

3.65

g/l

0.35

260

2511

(3007566) Smooth muscle Ab [Titer] in Serum

226

2132

1.01

0.04

1.2

181.11

147.36

titre

0.17

178

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

123

0.93

0.03

1.0

1.2

107.32

48.30

u/ml

1.27

118

(3013707) Erythrocyte sedimentation rate by Westergren method

6567

62492

1.00

0.03

4.2

4.4

14.04

12.73

mm/h

10.63

5971

57612

(3030981) Hyaline casts [#/volume] in Urine by Automated count

364

3489

0.99

0.03

2.3

2.4

0.33

0.31

e6/l

0.08

354

3344

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

219

0.96

0.03

1.0

1.2

260.75

320.76

pmol/l

0.37

148

(40768797) Stomach Pathology biopsy report

1267

12032

1.00

0.03

1.2

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

125

1.07

0.03

9.0

6.8

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

127

1195

1.01

0.03

1.1

1.2

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

305

0.97

0.03

1.1

97.43

702.03

ng/l

—

(3034770) Mitochondria Ab [Titer] in Serum

224

2150

0.99

0.03

1.2

221.67

1041.89

titre

—

106

(3045424) Erythrocytes [Presence] in Urine

149

1433

0.99

0.03

1.5

—

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

713

1.02

0.02

2.3

2.2

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

304

0.97

0.02

5.9

4.1

—

(3045414) Leukocytes [Presence] in Urine

416

3978

1.00

0.02

2.0

1.9

—

(3007164) IgA [Mass/volume] in Serum or Plasma

1635

15595

1.00

0.02

1.5

1.3

2.25

2.34

g/l

0.83

868

8786

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

169

0.96

0.02

1.6

2.6

6.27

7.20

mmol/l

—

105

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

3753

35720

1.00

0.01

2.0

99.70

99.83

pmol/l

0.05

1626

16229

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

376

3569

1.00

0.01

1.1

1.04

1.49

u/ml

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

608

0.99

0.01

1.1

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

688

1.01

0.01

1.1

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

688

1.01

0.01

1.1

1.2

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

149

0.96

0.01

1.3

1.2

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

511

4857

1.00

0.01

2.5

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

689

1.01

0.00

1.1

1.2

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

283

2702

1.00

0.00

1.9

1.4

9.80

9.98

g/l

0.31

242

2317

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

284

2711

1.00

0.00

1.9

1.4

3.02

2.96

g/l

0.41

244

2338

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

166

1.03

0.00

1.1

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

1.04

0.00

2.9

—

34.49

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

682

1.01

0.00

1.1

1.2

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

128

1215

1.00

0.00

1.1

8.70

16.97

au/ml

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

117

0.98

0.00

1.0

1.1

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

166

0.98

0.00

1.1

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

716

6817

1.00

0.00

2.7

2.8

190.90

185.21

ng/l

0.13

654

6222

(3024932) HLA-DR beta [Type]

129

1.03

0.00

1.1

1.0

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

484

1.00

0.00

1.1

1.0

2.84

5.56

nmol/l

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

684

1.00

0.00

1.1

1.2

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

684

1.00

0.00

1.1

1.2

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

239

2278

1.00

0.00

1.9

1.4

37.68

37.78

g/l

0.09

199

1903

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

119

0.96

0.00

2.1

2.8

0.83

0.82

u/field

0.03

119

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

221

2105

1.00

0.00

2.1

10.78

11.01

mg/l

0.18

202

1925

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

189

1.01

0.00

1.0

1.1

—

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

1.00

0.00

1.1

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

350

1.01

0.00

1.6

1.4

17.08

15.58

pmol/l

0.94

291

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

158

1.02

0.00

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

191

1.00

0.00

1.0

1.1

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

188

1.01

0.00

1.0

—

(3027859) Formaldehyde IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

0.95

0.00

1.0

1.1

9.40

13.60

u/l

—

(3050794) Legionella sp Ab [Presence] in Serum

1.00

0.00

1.0

1.1

—

(40760866) Procollagen type III.N-terminal propeptide [Units/volume] in Serum

0.00

0.0

1.0

—

(3041806) Other cells [#/volume] in Blood by Manual count

0.95

0.00

1.5

—

(40765089) Chromosome analysis panel - Blood by G-banded

0.85

0.00

1.0

—

(40761593) Coagulation factor VIII Ab [Presence] in Platelet poor plasma by Immunoassay

0.00

-0.00

0.0

1.4

—

(3016135) IgD [Mass/volume] in Serum

0.00

-0.00

0.0

1.2

—

246.87

—

(3029612) Listeria sp Ab [Titer] in Serum

0.00

-0.00

0.0

1.2

—

(3001409) Leptospira sp IgM Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

0.98

-0.00

2.3

2.4

—

(3003593) Leptospira sp IgG Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3014171) Thiocyanate [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.4

—

175.00

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

0.97

-0.00

1.2

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

0.87

-0.00

6.0

4.6

—

(3042628) Porphyrins [Moles/volume] in Urine

0.00

-0.00

0.0

1.0

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

0.87

-0.00

1.0

1.1

—

(3029396) Erythrocyte agglutination [Presence] in Blood

0.93

-0.00

1.7

2.8

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.6

—

2.12

—

(3003675) Hemoglobin [Mass/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.98

-0.00

1.0

1.1

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

0.00

-0.00

0.0

1.0

—

(3001218) Citrate [Mass/time] in 24 hour Urine

0.00

-0.00

0.0

1.7

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

0.00

-0.00

0.0

1.2

—

(3018291) Platelet Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3000876) Codfish IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3018910) Alkaline phosphatase.bone [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

1.01

-0.00

1.0

17.80

52.33

u/l

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3025504) Homovanillate [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.1

—

(3035153) Lemon IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: C3_BREAST_ERNEG_WIDE – Malignant neoplasm of breast, ER-negative, including Hilmo

GWS hits: 19

This endpoint is excluded (different definition than used in FinnGen).

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Malignant neoplasm of breast, ER-negative, including Hilmo

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Malignant neoplasm of breast, ER-negative, including Hilmo (C3_BREAST_ERNEG_WIDE)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints